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INTRODUCTION 
 Siddha system of medicine is an Indian traditional medical system.  
It is considered as one of the most unique system.   
Siddha Maruthuvam 
 This branch of medicine which was originated by the ancient 
siddhars of  Tamilnadu, it is described that humanity will not get old will 
they develop grey hairs, old age will be defeated, and death cannot 
overtake them.  They will like to a good, healthy, happy age for long. 
In tamil the objectivity of the maruthuvam is summed up, here under  
 åç«, \«ðD, J©Ã¤BV, å_é c¦D¸ª«VF, 
 \«ðt_éV© ØÃòkVµ¡ kVµÍ]¦ 
 kaçB kzÝ>m, EÝ> çkÝ]BD. 
THE AUTHOR OF SIDDHA MEDICAL SCIENCE 
The Divine Theory 
 As the origin of languages was ascribed to the god, so also the 
author of siddha medical science was also ascribed to god siva.  In the 
scientific and materialistic view, the divine origin of language or the 
medical science could not be accepted.  The ascribed authorship of god 
siva may also be not tenable.  However in the dim past, there ought to 
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have liked in a person possibly with the name of siva as the cult of lord 
siva is noticed in all the five continents. 
 The word siddha has derived from the word siddhi which literally 
means, attaining perfection in life or even it may be termed as Heavenly 
Bliss. 
 According to ‘ Thirumular ’ theory it is said to be medicine means 
that which ensures physiotherapy, psychotherapy, preventive as well as 
constructive and the conquest of death. 
 The human body is made up of  panchabuthas, like the world.  
Siddha medicines are also prepared on the basis of panchabuthas. 
  \õ½èÍ> WKÐD 
  Wé¼\Í]B s·DAD 
  s·D¯ç>kò k¹¥D 
  k¹Ý>çé ÖB y¥D 
  yx«èB ÀòD ¨[ÅVºz 
  nDØÃòD ¯>Ý]Buçï  ‡ AÅD 2. 
 Siddha system is based on the vedic scriptures.  It is practiced 
extensively in the Southern State of Tamilnadu.  This system of 
medicine is concerned with the Herbals, Metals, Minerals and their 
combinations. 
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PURIFICATION PROCESSES IN SIDDHA SYSTEM 
 Nature has created innumerable plants, herbals, metals, poisonous 
substances, minerals, salts and other organic substances.  The siddhars 
had selected such of those things which can render relief, to innumerable 
ailments of mankind suffered and is suffering.    Everybody wonders 
how it was possible in those primitive days, when modern science had 
not developed.  Without any laboratory or microscope, ailments and their 
remedy.  It was possible only due to their super human powers 
attained through yogic practices. 
 According to siddhantic doctrines, everything found in nature has 
two qualities good and bad. 
 Every raw drug used in siddha medicine is purified before 
preparing it as a medicine. 
 Before the preparation of medicine, the ingredience of the 
medicine, which consists of herbals, metals, minerals etc., are subjected 
for purification.  During this process, the molecules of the metals or 
Herbal becomes fragile and non toxic.  This is done by super heated and 
triturating with several herbal animal products, mostly herbs and metals, 
are purified by Marana.  (ÄÝò, tÝò) 
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After purification, drug is, 
 To make them absolutely non-toxic.  
 To make them easily absorbable by the intestinal mucosa and to 
make them assimilable through the walls of the cells. 
 To enchance their therapeutic efficacy, so that these could be 
administered in a very small dose. 
 To make their therapeutic effects for a long period and 
 To make them easily for consumption. 
 Toxicology is the study of the nature and mechanism of toxic 
effects of substances on the living organisms and other biologic systems.  
It also deals with quantitative assessment of the severity and frequency 
of these effects in relation to the exposure of the organism. 
 In fact, every substance is theoretically capable of producing 
toxicity and every drug is potentially a poison for routine purposes.  In 
pharmacological parlance, a poisonous subject has a low therapeutic 
index. 
 Drugs are substances, which used in the treatment of diseases may 
produce beneficial effect with minimum bad effects.  A higher dose of 
these drugs will be needed to produce toxicity.   The toxic effect may 
manifest immediately (acute) or after a prolonged or repeated 
administration of the substance (chronic). 
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 Toxic effects may occur after the administration of a substance for 
therapeutic purpose.  This may be because of anaphylaxis, Idiosyncrasy, 
or unintentional over dosing.  When over dosing occurs during a therapy, 
an element of negligence may be involved, which is of prime importance 
from a legal point of view.  For a practicing physician, awareness about 
this aspect is highly importance. 
 Certain substances that are used in food and medicine are liable to 
cause death or damage to the body.  Therefore it is essential to keep in 
mind about the antidotal medicinal substances by all. 
 In siddha system of medicine is better, because of their formulation 
are found to have lesser side effects.  Following the siddha system, all 
will live happily with good health in the eugenical eco system.  In order 
to the acceptance of siddha medicine by the world, certain basic studies 
like pharmacological, toxicological studies are necessary for the way to 
Standardization of siddha drugs 
 The properties of the prepared compounds (medicines) are different 
from those of the raw materials.  All drugs are toxic in over doses. 
 “ Too much of anything is good for nothing ” 
 Even therapeutic dose  range of many drugs have unavoidable toxic 
side effects.  Thus it is essential to screen a drug for its acute and chronic 
toxic potentialities before it is introduced for human usage. 
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 Standardization studies occupy an important place in both clinical 
and drug research programme, since it provides exact data for obtaining 
genuine drug and authentically prepared compound medicines. 
 In siddha system of medicine, medicines are classified broadly as 
¾ Aga marunthugal (Internal medicine)     -   32 
¾ Pura marunthugal (External medicine)   -   32 
The author dissertation topic NABI MATHIRAI comes under 
mathirai in aga marunthu classification. 
 Nabi is one of the widely used siddha medicine in general practice 
and also nabi is the one of the cardiac poison.  After purification it is 
used as suram (fever) in siddha medicine.  So, to assess its safety and 
toxicological effects, the author has selected this drug for detailed study 
through this dissertation work. 
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AIM AND OBJECTIVES 
 
“ Toomuch of anything is good for nothing” 
Nabi mathirai, is high potency drug comprising mainly, 
1. Nabi 
2. Vengaram 
3. Milagu 
 As major ingredients which are good for their anti pyretic 
properties is being  used  by  many of the traditional practioners, 
nowadays it is also used to cure all kinds of Sura noigal (Fever). 
 On the other hand the ingredients of Nabi mathirai are basically 
heavy toxic substances.  Administration of these substance, without 
proper purification, (suthi).  In human body may lead to severe 
complications even death also.  Because, Nabi, vengaram are well known 
toxic substances and many of siddha literature speaks about it. 
 Hence the main aim of the dissertation work is to study the toxic 
effects of  Nabi mathirai  short term and long term administrations.
 The prime object of this study is to find out the acute and chronic 
toxicity study. 
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♠ Acute toxicity study 
♠ Chronic toxicity study 
♠ Hematological investigations 
♠ Histopathological study of the organs such as kidney, heart and 
liver in albino rats  
♠ Bio chemical analysis  
♠ And Statistical  Analysis of the medicine  Nabi mathirai. 
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MATERIALS AND METHODS 
 
Selection of Drug 
  “NABI MATHIRAI  mentioned in “Skitcha Rathna 
Deepam ennum Vaithya Sinthamani II part” was chosen and 
prepared as per the procedure mentioned below the drugs were collected 
from the local market, through proper identification. 
The ingredients of NABI MATHIRAI are 
# NABI 
# Venkaram (Borax) 
# Vellai milagu (white pepper) 
# Inji (Zingher officinale) – (ginger juice) 
PURIFICATION (SUDDHI) OF RAW DRUGS 
# NABI   
 The roots are soaked in cow’s urine for 3 days and then 
dried. 
# Venkaram (Borax) 
 The borax is fried to be free from moisture. 
# Vellai Milagu  
 Vellai milagu is fried in a mud pan it make it moist free. 
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Method of Preparation 
 I adopted the method of prepation of Nabi Mathirai from sikitcha 
   Rathna Deepam ennum vaithya sinthamani  II part. 
Ingredients 
Purified Nabi   - 2 varagan (8.4g) 
Purified Venkaram - 10 varagan (42g) 
Purified vellai milagu - 10 varagan (42g) 
Ginger Juice  - adequate amount 
ÖkuçÅ ï_kÝ]oâ| >MÝ>MBVï å[ÅVï ØÃV½Ým, ¸[ ÖÞEß 
ÄV® sâ| 4 x>_ 5 \è ¼å«D kç« Î¼« ¶ç«©ÃVï ¶ç«Ým táz 
¸«\VðD \VÝ]ç« ØÄFm céìÝ] ¨|ÝmÂ ØïV^á ¼kõ|D. 
¶á¡    
   1 x>_ 2 \VÝ]ç« (60-160 t.þ.) Öò¼kçá.  
yòD ¼åVFï^ 
   ·«D, >çéko, 
   \õç¦zç¦ßÄ_, >çéÃV«D, 
ÃÝ]BD    
   ÖßÄVÃÝ]BD, A¹ >^á¡D. 
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\VÝ]ç« s] 
 \VÝ]ç«ï^ ØÄF¥DØÃV¿m ¶]_ ¼ÄòD Ä«Âzï^ ¨_éV 
kuçÅ¥D ó«èÝm ï_kÝ]oâ| ØÄV_olòÂþÅ ¶ÐÃVªºï¹_  
çïl_ Îâ¦V\oòÂzDÃ½ ¶ç«Ým \VÝ]ç«ï^ ØÄFm ¶]K^á  
Àì cé®þÅ kç«lKD WwoKìÝ> ¼kõ½Bm.   \VÝ]ç«ï¹_  
Ö«ÄD, ïÍ>ïD x>oBçkï^ ¼ÄìÂï ¼kõ½lòÍ>V_, ¶çkïçá 
ØkË¼kÅVï ï_kÝ]_ Ö½Ým ¸Åz \uÅ Ä«Âzïçá íâ½Â  
ØïVõ| ÄïéxD ïéÂzDÃ½ ¶ç«Âï ¼kõ|D. 
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REVIEW OF LITERATURE 
SIDDHA ASPECT 
åV¸ (NABI) 
¼k®ØÃBìï^ :  åV¸,  
åVÃD,  
kÄåV¸, (ÃßçÄåV¸),  
kÝÄåV¸,  
s¦D,  
\ò>D. 
English :  Indian aconite, monk’s hood. 
Tamil  :  Vatsanabi 
Sanskrit  :  Vatsanabi 
Hindi  :  Bachhang 
Malayam : Vatsanabhi. 
 Öàm Ö\B\çél[ ¶½kV«D x>oB åV|ï¹_ Ãl«VzD ØÄ½ 
Ö>[ WÅÝç>© Ãu¤, Öm åV[zs>\Vï ¸öÂï©Ãâ½òÂþ[Åm. 
1. ØkõåV¸, 
2. ØÄÍåV¸, 
3. ÀéåV¸, 
4. ïòåV¸, 
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ÃB[Ã|D c®©A  : céìÍ> þwºz 
·çk    :  çï©A,  
>[ç\    : Øk©ÃD,  
¸ö¡    :   ïVì©A 
ØÄFçï 
 sBìçk©ØÃòÂþ ‡ ü¼>kïVö   ‡ Diaphoretic 
 E®Àì©ØÃòÂþ  ‡ JÝ]«kìÝ]M   ‡ Diuretic 
 xçÅØk©Ãïu¤  ‡ xçÅsBV]¼«V]  ‡ Antiperiodic 
 mB«¦Âþ  ‡ ¼k>ªVÄVÍ]M   ‡ Anodyne 
>VÃ\ïu¤  ‡ cÂ«¼«VïÄ\ªïVö   ‡ Antiphiogistic 
Øk©Ã¦Âþ          - Antipyretic 
JìßçÄ¥õ¦VÂþ ‡ WÝ«ïVö       - Narcotic 
>VmØk©Ãïu¤ ‡ Ä\ªïVö        - Sedative. 
zðD :   åV¸l[ ØÃVmÂzðD 
kV>ko \Í>\Å_ \VÅVÂ ïÃ©¸èï^ 
Îmzâ| z[\Í¼>Vì {|ºïVõ ‡ ïV>éì>D 
AÝ]¼BV ¦VòlòD ¯¡D kçázw¼é 
·Ý] ØÄF> åVsl[¼Ãì ØÄV_ 
(¶ïÝ]Bì zðkVï¦D) 
14 
 
ØkõåV¸ 
 Ö>uz© ØÃò¼åVF, ïVðVÂï½åÞ·, óçé, \VìçÃ Tºïß  
ØÄFþ[Å ¼åVFï^, z[\D, ·«D Öçk Ø>Vçé¥D. 
zâ¦º ï½óçé í|Aök[þòt 
mâ¦z[\ kV>Í Ø>Vçé¥ºïVõ ‡ kâ¦xçé© 
ØÃõ¼ð ·«Í>è¥D ¼ÃòéïÝ>Vì ÃçïÂzD 
ØkõðVs >[çª sòDA.  
2. ØÄÍåV¸, kÄåV¸, ÃßçÄåV¸ 
 Öm zçÅ¼åVF, åÞ·, x©¸è, z[\D, ¨KD¸[ó|, ·«D Àì 
¼kâçï Öçkïçá séÂzD. 
 ï½BØ>Vò zâ¦º ïªÝ> s−Ä[M 
 ØïV½BØ>Vò z[\D óçé¥D Ã½l_ 
 >s«Ý] Øk©A¦¼ª >Vï·«D yòD 
 káì ÃßçÄ åVs>çª kVµÝm     (¶ïÝ]Bì zðkVï¦D) 
3 ÀéåV¸ 
 Ö>uz åVØkVâ½Â ïVFßÄ_, å¿þB ~«_, Aõ, A¿¼åVF,  
k_çéÂ ïâ½, ïsçÄ yòD. 
 ¶õðVß ·«D¼ÃV tÅºïD¸ Tï\V®D 
 AõðV®D »®D A¿ØkVa¥D ‡ >õðVòD 
 k_çé ïsçÄØBª çkBïÝ¼>Vì ØÄV_o| ¼åVF 
 Ö_çéØBVò ïVìåVsÂ ¼ï. 
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4. ïòåV¸ 
 Ö>ªV_ ·«D, x©¸è, >çé¼åVF, ¨ö©A¿, ÃVDAï½, c^Aõ 
zçÅ¼åVF, ¼>^åÞ· ÀºzD. 
 ïVFßÄ_ >çé¼åVF ïªÝ>Ä[M ÃV>Ø\ö 
 ¯ßE s¦Âï½¥â Aõzâ¦D ‡ íßÄo|º 
 ïVÝ]«Ý¼> Óºz½¼ÃVD ïV«áï© çÃºØïV½¼B 
 óÝ]« ÅsÂzÝ mkõ|. 
 Öm, x©¸èÂïVïß ØÄF¥D \VÝ]ç«ï¹_, Îò xÂþB\Vª  
Ä«ÂïVFß ¼ÄìÍm ¼\uí¤B ¼åVFïçá séÂzD. 
\òÍm xçÅï^ (kwÂz) 
 åV¸, ØïÍ], táz, oºïD, ØkõïV«D 
Öçk kçïÂz 4 þ«VD¨ç¦, ]©¸o 8þ«VD ¨ç¦ ÖkuçÅ »\Ýç> 
ÖçéßÄV® sâ| ¶ç«Ým táïá¡ \VÝ]ç«ïáVï ØÄFm Î[®  
¶_ém Ö«õ| \VÝ]ç« T>D ØïV|ÂïéVD.  Ö>ªV_ x©¸è¥D  
¼ÃVD.  
 åV¸, ÄV]ÃÝ]ö, táz, ÖékºïD ¶_ém ïòkV©Ãâç¦  
kçïÂz 4þ«VD, ¶DÃì 2þ«VD ïü#ö 1þ«VD¨ç¦ ¨|Ým ÖkuçÅ  
¶ç«Ým, táz ¶á¡ \VÝ]ç« ØÄFm, ¼kçáÂz 1 \VÝ]ç« T>D 
Öò\_ Öç«©A x>oB ¼åVFïÓÂz kwºïéVD. 
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 åV¸ 8þ«VD ¨ç¦, ¶Â«ïV«D 8þ«VD ¨ç¦, ÖÍm©A 20þ«VD ¨ç¦
ÖkuçÅÝ máE ÄVuÅV_ Ø\¿z¼ÃV_ ¶ç«Ým çï, ïV_ TÂïº 
ïÓÂz© ¯ÄéVD. 
 åV¸, ¶¸[ Ö«õ|D {Ø«ç¦ ¨|Ýmß ÄV«VBDsâ| Ø\¿z¼ÃVé 
¶ç«Ým å«DAß EéÍ]Âz çkÝmÂïâ¦ A¿ Øk¹©Ã|D. 
 Öç> zçÅ¼åVF, ÃVöÄkV¥ x>oB ¼åVFïÓÂzD kwºzkm
cõ|. 
åV¸ ¼ÄòD \òÍmï^ (EÝ> çkÝ]BÝ ]«â|) 
1. Ö«Ä ¯Ã] \VÝ]ç« 
2. Ö«VÛ«V¼Ûük« \VÝ]ç« 
3. ¨\>õ¦Âz¹çï 
4. ï¼ðÄÂz¹çï 
5. ï«kVékl«k \VÝ]ç« 
6. ï_BVð kl«k \VÝ]ç« 
7. ¼ïV¦V óöÂz¹çï 
8. ÄÞæs \VÝ]ç« 
9. Ä[MÃV> kl«kD \VÝ]ç« 
10. óçéÂz¦V« \VÝ]ç« 
11. óçé¯Ã] \VÝ]ç«  
12. ïÍ] \VÝ]ç« 
ÃVìk] Ã«èBD ¨[ÐD s− çkÝ]B EÍ>V\è 
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 Ã«Þ¼ÄV] s¦Â zwDA ‡ Äïé s¦ºïâzD 
 \ïV EÍ>V\è zwDA, ÄÞæs zwDA, ÄÞæs ï«è ç>éD,  
Ã«Þ¼ÄV] \VÝ]ç«, \ïV Ã«Þ¼ÄV] ç\. 
1. Ö«Ä ¯Ã] \VÝ]ç« 
 ïì\\VÞ ÄÍ] sçªØBéV Ø\VaBÂ 
  ïw®k[ z¹çïl[ kçïï^ 
 \ì\\VD «ÄÝ][ ¯Ã] ¥ç«Âþ_ 
  \VöéVß ........................................ 
 ïì\t_ éV> åV¸¥ xòÂzD 
  ......................................................... 
 ............................................................ 
 ÃMB¼k BÐÃV ªÝ]oÂ z¹çï 
  Ãl[¤¦ J[®åV^ >V¼ª. 
ØÃVò^ 
¼ÄòD Ä«Âzï^ 
 Ö«ÄD, ïÍ>ïD, ïòåV¸, còÂz, >VD¸«©ØÃV½ Ä\¶á¡       
Öçkïçá xçÅ©Ã½ ·Ý] ØÄFm, ØÄ®©Ãç¦ß ÄVuÅV_ J[®åV^  
¶ç«Ým ØkloKìÝ]© ØÃV½Ým, æçé\õ ØÄF> ïVEÂz©¸l_  
¶ç¦Ím, \ð_ ÖBÍ]«Ý]_ çkÝm 12 ÄV\D ¨öÝm gÅsâ|  
¨|ÝmÂ ØïV^á¡D.  ¸Åz ÖÞEÂÄVuÅV_ å[ÅVï Îò ÄV\D  
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¶ç«Ým cÓÍ>ákVï¡D, táïákVï¡D còâ½ céìÝ]Â  
ØïV^á¡D. 
¶ÐÃVªD   ‡  >õ§ì 
¶á¡   ‡  1 z¹çï 
yòD ¼åVFï^ 
 Ä[M  
 z¹ì·«D  
 óçé 
 s−ºï^ 
ÃÝ]BD 
¨^, ï|z, A¹, \VtÄD, çï©Aß ·çk¥^á ØÃVò^ï^ gïVm. 
2. ï«kVé kl«k \VÝ]ç« 
 ¶]ïV« kVé kl«k xçÅÂþ_ 
  ¶«[sÍm ÄÂ] ØBkVßÄV«D 
 .............................................................. 
  m]ØBkVßÄV« ïÍ>ï åV¸ 
 .............. z[¤ Bás½ é¸WBV 
  ÄçªÝm«Ý ]|\m ïVõï. 
¼ÄòD Ä«Âzï^ 
 Ö«ÄD, ÄÝ]ßÄV«D, ¨kVßÄV«D, Ã½ïV«D, ]öï|z, ]öÃçé,  
ØïV½¼ko, nÍm©A, ïÍ>ïD, åV¸, ØÃòºïVBD, ¸«õç¦, ïVâ|Â 
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ïòçð, ¨òÂï[¼kì, ·Ý]Ým xçÅ©Ã½ #^ ØÄFm, ï_kÝ]_  
¨òÂï[¼kìÂ z½ÀöªV_ Ö«õ| åVáç«Ým céìÝ]Â z©¸l_ 
¶ç¦Ým, \ð_ ÖBÍ]«Ý]_ çkÝm ÖòÄV\D ¨öÝm, ¸Åz åVF©  
¸ßEªVéç«Ým z[¤Bá¡ \VÝ]ç«ï^ ØÄFm céìÝ>¡D. 
yòD ¼åVF  :  ¶¸WBVÄ Ä[M yòD. 
3. ÄÞæs \VÝ]ç« 
 Öòs åV¸ Bö>V« t«>º ïÍ>ïD ØkºïV«D 
 kò¼\ >V[¤Â ïVFß·Âz kòÍm táz ]©¸o¥D 
 >ò¼\ kçïØBV[ ¼åVìïwÍ· >V¼ª kVáç\ºïwÞ· 
 ¶òç\ ·Ý] ØÄF]éÂï \Vª ïwÞ· Ã]çªÍmD 
 ................................................................................................. 
ØÃVò^ 
 Öòs, åV¸, ¶ö>V«D, Ö«ÄD, ïÍ>ïD, ØkºïV«D, >V[¤ÂïVF,  
·Âz, táz, ]©¸o kçïÂz 11/4 k«VïØªç¦ ¼åìkVáD 61/4  
k«VïØªç¦ Öçkïçá xçÅ©Ã½ ·Ý]Ým >MÝ>M© ØÃV½Ým,  
ï_kÝ]oâ| çïBVÍ>ïç« ÄVu¤_ °¿åV^ å[ÅVï ¶ç«Ým  
z[¤Bá¡ \VÝ]ç«ï^ ØÄFm Wwo_ céìÝ>¡D. 
¶ÐÃVªD yòD ¼åVFï^ 
 1z¹çï ÄV]ÂïVF z½Àöo¦ JékVF¡ yòD. 
 ÃVDAÂï½ ‡ ÃwßÄVu¤_ >«¡D. 
 ïVBD ‡ Øk^áVâ|©ÃV_. 
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Äì¼k·« «ÄD 
 ØkõïV«D ÄV]oºïD ¼\é« t«>ïÍ>D 
 ÎõïVð åV¸ WçÅ ¼BVç«Ím ‡ ¶[ÃVF 
 ØïV½¼ko ØkÍ>Àì íâ½Bç« z©¸¥^¹_ 
 ¶ç¦so| \õ æçé gFÍm. 
 gFÍ>\õ æçéØÄFm gu®\ðØéÍ]«Ý][ 
 °FÍ> sòÄV\ Ø\ölâ| ‡ ÎFÍ>¸[A 
 z[¤Básâ¦V_ ØïV½B·«D ¼>V¦D¼ÃVD 
 Øk[¤Äì ¼kÄ«D ¼Ãì s^. 
¼ÄòD Ä«Âzï^ 
 ØkºïV«D, ÄV]oºïD, Ö«ÄD, ïÍ>ïD, åV¸ (Ä\ ¶á¡) 
ØÄFxçÅ 
 ØïV½¼koÂ z½Àö_ ¶ç«ÝmÂ z©¸loâ| æçé\õ ØÄFm,  
kVKïVBÍ]«Ý]_ Öò ÄV\D ¨öÝØ>|Ým g¤B¸[ ¶ç«ÝmÂ  
ØïV^á ¼kõ|D. 
yòD ¼åVF  : ·« ¼>V¦D 
T« sÂþ«\ «ÄD 
 ¨â½sç« åVs Ö«>D ÖÍm©A ÃV>«ÄD 
 ïâ½© ØÃòºïVBD ØkõïV«D ‡ Îâ½B¼>Vì 
 ]©¸oJ éÝ]ØªVò ¼Ä«sâ| ¼åìØÃV½BVBVF 
 ØÄ©AÀì ]©¸o JéD ¼Äì. 
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 ¼ÄòD þÄVBÝ][ ØÄöÍ#Ä_ ÖâØ¦öÝm 
 gÅ¼k ÃõèB>[ ¸ß·ß ‡ ¼Ä«kç«Ý 
 mõbz[¤ \VÝ]ç«l_ ¼>V¦·«D ¼ÃV|D 
 cõbT« sÂþ«\D Îì.    
     ‡ ¶ïü]Bì çkÝ]B EÍ>V\è ‡ 1092 
¼ÄòD Ä«Âzï^ 
 ¨â½sç>, åV¸, ÖÍm©A, ÃV>«ÄD, ØÃòºïVBD, ØkºïV«D,  
]©¸oJéD (Ä\ ¶á¡). 
ØÄFxçÅ
 ÖkuçÅ ]©¸oJéÂ z½Àö_ méVBÍ]«\Vï ¨öÝm g¤B¸[ 
Ã[¤© ¸ß· ¼ÄìÝ>ç«Ým z[¤Bá¡ \VÝ]ç« ØÄFm ØïV^á  
¼kõ|D. 
yòD ¼åVF  : ¼>V¦·«D 
¸«\VåÍ> Ãl«kD 
 ¦ºïðD Ãç« åV> ïõ½ÃD 
  >V«\VD s¦ åVï«D 
 >ºïÓÂ Øïç¦ >V[WçÅß Äö 
  ÛV]oºï¼\V ¼¦¿¼\ 
 ¶ºïm^ s¦ \Vu¤ B_éÀ 
  «Vâ¦ åu¤ª \V\è 
 Äºï öÝ]| tÞE Àì\m 
  ÄVuÅß ÄÍ] ·«ºï¼á 
     ‡ EÝ> çkÝ]BÝ ]«â|. 
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ØÃVò^ 
¼ÄòD Ä«Âzï^ 
 ØkºïV«D, ïÍ>ïD, \¼ªVEçé, ¶ö>V«D, åV¸, ·Âz kçïÂz 1
 Ãºz, ÖoºïD 6 Ãºz, Öçkïçá xçÅ©Ã½ ·Ý] ØÄFm, ÖÞEß 
ÄVu¤_ å[ÅVï 1 åV^ ¶ç«Ým, táïá¡ \VÝ]ç«ï^ ØÄFm  
Wwo_ céìÝ>¡D. 
¶ÐÃVªD  : ¼>[, ÖÞEßÄV® 
¶á¡  : 1 \VÝ]ç« 
yòD ¼åVFï^ : Ä[M·«ºï^ yòD. 
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åV¸ åÞ·Â z¤zðD 
 
 Öm \òÍm ØÄFk>uz ÃB[Ã|Ý>©Ã|þÅm.  #Fç\ ØÄF¥D 
xçÅ >k¤ªVKD ¶á¡Âz ¶]ï©Ã½ÐD Îòkçï åÞ·Ý>[ç\çB
sçásÂzD. 
åÞ·Â z¤zðD 
 åVÂz, kVF, xïD Öçkï^ s®s®©Ã¼>V|\_éV\_ ]tì¸½Ý
>m ¼ÃV[¤òÂzD  åç\ßÄKD c¦D¸_ ko¥D cõ¦VzD.  c¦DA 
Açï WÅ\VzD.  klu®Âï|©A , ·çkl[ç\, kVÍ] ¼ÃV[Åçkïçá
 cõ|ÃõbD.  ¸[A kVÍ]l_éV\_ gzD.  åV½ >áìÍmD zçÅÍ
mD cðìßEÂzÝ ¼>V[ÅVç\, gwÍ> JìßçÄ, ÃékçïBVª ïª¡Ý 
¼>VuÅD, °uÃâ| \ª ¶ç\]¼BV| #ºïVç\, ¶½kl® ïªÝ>_, ¨ò
kVFï|Ým© ¼Ã]BV>_, ¶]_ E¤m zò] Tµ>_, sÂï_ ¼ÃV[Åçk
ï^ cõ¦VzD. 
   
  åVsÂ þwºz ][ÅVÂïV_ 
  åV|º zðÝç>Ý >Vª¤Tì 
  ¼\s ØB¿DAD Ã«>VÃD 
  ¼\o éªKD *¤kòD 
  ís BkòD sBìçk¥¦[ 
  íìsa EkÂzD xïD¼kÅVD 
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  gs BaÂz *m*¤_ 
  ¶çÅÍ>Vì åÍ] ¶kMl¼é. 
ØÃVò^ 
 Ã«>VÃD ¼\o|D, c¦DÃV_ ¶ª_ cõ¦VD, íßÄo¦ çkÂzD,
 sBìÂzD, xïD ¼k®Ãâ| ïõ saï^ EkÂzD.  ÖÍ]é clç«©  
¼ÃVÂzD. 
åÞ· x¤¡ 
  ¼ÃVzD Ã½Â¼ïV «¡−Ýç>© 
  Aï_¼k[ Ã·s[ ØåFØïV|À 
  >VzD E®ÿç«ß ÄV®D 
  >MÝ> ¼\¦Ý m¦ÀòD 
  gzD Ã½À Ø>V|Ý]Aþ_ 
  ¶ïK \_éV_ ØåFíâ| 
  °z tmï^ ïõ¦¡¦[ 
  ¨[¼Å ¥çÅÍ>Vì åÍyÄì. 
 Ã·s[ ØåF, ¸Åz E®ÿç«l[ ÄV®¦[, Øk^áVâ| Àç«¥D  
¼ÄìÝmÂ ØïV|Âï ¼kõ|D. 
 
EÝ> \òÝmkD (¶ïü]Bì s¦©¸«] s¦Ý]«â| ‡ 29) 
 åV¸][¼ÅVìïâ| åu ïVEM ¼kç« 
 ¼\M¼B BV[ÃVØªF sâ¦ç«Ýmõ ‡ gsØªFlì 
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 Ã[¤sâç¦ ØïVõ¦ç«Ýmð Ãõbï|Â ïVFÂ z½Àì 
 ¨õb\ç> ¼ÃVâ| tBDA. 
 ÖBDA>« ¼ÄVþsÝç> ¼BuÅ ·ç« ØåFl_ 
 åBD ØÃÅÀ ¥õA¦¼k åVâ| ‡ kBD ØÃòz− 
 ØkõïV«Í >[ç\x[ØªF sâ¦ç«Ým å[táçï 
 Ã[Ø\VaBV ¥õA¦À ÃVì. 
1. ïVEMl[ ¼kç«© Ã·s[ ÃVoéVkm, ØåFléVkm, ¶ç«Ým  
åÞE[ k[ç\ÂzÝ >Âï åV^ ¶á¡ cõð ¼kõ|D. 
2. Ã[¤ \éÝç>© Ã·s[ ØåFBVéç«Ým cõðéVD. 
3. ï|ÂïVFÝ ¼>Vçé s]©Ã½Âz½Àì ØÄFm cõðéVD. 
4. AÝ]«¼ÄVþ s>çB© Ã·s[ ØåFBVéç«Ým cõðéVD. 
5. ØkºïV«Ýç> Ã·s[ ØåFBVéç«Ým cõðéVD. 
6. táçï© Ã·s[ ØåFBVéç«Ým cõðéVD.  z½Àì ØÄFm  
z½ÂïéVD. 
7. ÃßçÄ tá[ »çª å[ÅVBç«Ým x^¹ÂïVBá¡ ¨|Ým  
Ã·s[ ØåFBVéç«Ým cõðéVD. 
\l_mÝ>Ýç> xçé©ÃV_ sâ¦ç«Ým cõ¦VKD åV¸lªV_  
°uÃâ¦ åÞ· ¼kïD >è¥D. 
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åV¸ ·Ý] xçÅï^ 
   
D åV¸Âþwºçï ¨|Ým ¼ïV\BÝ]_ 1 åV^ cçÅ©¼ÃVâ|  
¨|Âï¡D. 
D ÃòÝ]lçé «ÄÝ]Ù¤ xÝ]çéÂz^ çkÝ> ·Ý] z©¸l_  
ØÄVòþ Îò åVa ØÃVòÝØ>|Ým æÍ]_ þBVwÝ]_ méVBÍ 
]«ºïâ½ ¨öÝm ¸Åz ¨òÂï[ ÃVo_ Äu® »¤ ¼ïVtBÝ]_  
»ÅÃ¦¼ÃVâ| ¨|ÝmÂ ØïV^á¡D. 
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ØkºïV«D  
SODII  BIBORAS,  SODI  BORAS,  SODIOM   BIBORATE, BORAX. 
¼k®ØÃBì 
  ÖßÄ«ÂzÂz© ØÃVöïV«D, ïV«D, còÂþªD, còÂz  
tÝ]«[, ¦ºïðD, #\Ýç>B¦Âþ ¨[Å ¼k®ØÃBì cõ|.  Öàm  
¶]ï ¶ás_ ïo¼ÃVìMBVsK^áª.  þ¹Bì °ölKD, ØÃò ¨[Å 
Ö¦Ý]KD ÖÍ]BVs_ ]ØÃÝ, ¼åÃVáD x>oB Ö¦ºï¹K^á °ö  
ï¹KD þç¦Âþ[Åm.  \õb¦[ ïéÍ]òÂzD ÖË¡DAÂ ïuïçá 
Àö_ ïç«Ým ¸ÅØÃVò^ïçá ÀÂþ \®Ã½¥D ïVFßE c©ÃVÂþÂ  
ØïV^á_ kwÂïD.  ïç¦ßÄ«Âzß ·Ý>\Vª>[®.  gçïlªV_  
¶>uz Ãºz ØkÍÀòD, E¤m ·õðVDAD íâ½ k½ïâ½, óöB  
Øk©ÃÝ]_ çkÝ>Vkm yloâ| ¨öÝ>Vkm ¶]K^á Àç«© ¼ÃVÂþ 
c©çÃ ¨|ÝmÂ ØïV^á ¼kõ|D.  ÖË¡©A Øk^çáBVF, Ø>¹kVF
Eé ¼ïVðºï¼áV| í½B>VF ØïVÞÄD tÐtÐ©ÃVF ÖòÂzD.  Öm
Àö_ ïç«¥D, ÄV«VBÝ]_ ïç«BVm.   ïVu®©Ã|DÃ½ çkÝ>V_  
c©¸[ ¼\_ ØkõèÅÝ#^ Ã½¥D ØkºïV«Ýç>© ØÃVöÝ>V_¶]_
ÖòÂzD Àì ·õ½©ØÃVöÍm ¶]_ E¤B mkV«ºï^ ¼>V[®D. 
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¼k®ØÃBìï^ 
 According to Bohar, the different names of vengaram in siddha 
medicine are stated as follows, 
 ØkõïV«© ØÃBì>çª¼B sáDÃÂ¼ïÓ 
 ¼\V]M¼BVì >ºïÓÂz ÎòÝ]ªx\VzD 
 ÄºïV«D ¼ÃVé¼k ÄÝØ>_éV\VzD 
 ÄÍ>Vª ØÃVöïVö z¼ÃVö ¼ÃVzD 
 ¶ºïVö \èÂïVö ¦ºïðx\Vþ 
 \¦ºïV> #\Ýç> B¦ºïD ÃõbD 
 ØÃVºïVö Ä«ÂzÂz tÍmò¼kBVª 
 ØÃVöïVö >ªÂþª ÄÍ> ¼Ãò\V¼\ 
     ‡ ¼ÃVïì Wïõ| 1200. 
1. ØÃVöïVö 
2. z¼¦Vö 
3. ¶ºïVö 
4. \èÂïVö 
5. ¦ºïðD 
6. #\Ýç>B¦Âþ 
7. ØÃVºïVö 
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 According to sattamuni the synonyms of vengaram are as follows, 
 ïVö ØÃVö ïVöz|D ¼Ã>ï\è 
 ¼åö¥òÂþçw ¼åìÍ> \èïV«D 
 kVöB >«\Ýç> \¦ÂþB EuÃö 
 ïVöB ÄÍ>Vè ïVÝ> z¼¦Vö 
      ‡ ¼ÃVïì Wïõ| 1200. 
1. ïVö 
2. ØÃVöïVö 
3. ¼Ã>ï\è 
4. còÂþçw 
5. ïV«D 
 According to Nigandu Rathnakaram, the synonyms of vengaram 
are as follows, 
 ¦ºïðD ¼éVï·Ý] ïV«ïD Ý«Vs¼BV| 
 ¦ºïð −V« \uçÅÝ >z]«V kðï\VzD 
 ØÃVºï \Vé]« vÝ][ ÄDÃkØ\[®D ¼ÃVu®D 
 Öºþçk ØkºïV« «ÝmÂ ¼ïu¤| åV\\V¼\ 
      ‡ Wïõ| «ÝåVï«D. 
¦ºïðD, ¼éVï·Ý], ïV«ïD, Ý«Vs, ¦ºïð−V«D, ÄDÃkD. 
 
 
6. #\Ýç> 
7. EuÃE 
8. ÄÍ>VM 
9. z¼¦Vö 
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ØkºïV« çk©A  
 Îò ØÃöB ÃVõ¦Ý]_ ¯À® 1 Ã½ (1.3o) >õ§ìÃ½ 8 (10.4 o) 
¼ÄìÝmÂ ïç«ÝmÝ Ø>¹Øk|Âï¡D.  Ö]_ Ãò©A© ¼ÃVé¡, Ãéçï 
ÃéçïBVï¡D cç¦Ým æªD ÃéD 100 (3,500 þ«VD) Øk½¥©A ÃéD 
61/4 þ«VD ¼ÄìÝm 1 ÃâÄD óöB Øk©ÃÝ]_ ïVBçkÂþ[ ï®ÂzD. 
 Öç> ¶|©¼Ãu¤ ï^¹·â¦ ÄVDÃ_ 1 ÃéD, (1.3o) z[¤BçéßÄV® 
1 Ã½, (1.3o) g\ðÂz ØåF 1/2 Ã½ (650t.o) íâ½ ØÃVºïV>kV®  
ï\éD ¼ÃV_ yJâ½ 4 åVaçï ¨öÝm kVBï[Å ÃVÝ]«Ý]_ »u¤  
Îò ÃâÄD Øklo_ çkÂï ØkºïV«\VzD. 
 ØkºïV«D 64 Ä«Âïá¡D ïâ|Ø\[®D, cÃ«ÄD 120¥D ÄÝ>VÂz
Ø\[®D, ïV«Ýç>Â ïâ|Ø\[®D ïáºz ØÄÍ#D ïò Öçkïâ|  
g]BVzØ\[®D Ö>[ \þç\ íÅ©Ãâ|^ám.   
         ¼ÃVïì ‡ 1000 
·çk (Taste) 
 ÖM©A¦[ í½B mkì©Aß ·çk¥ç¦Bm.  Ö>u® TöBD Øk©Ã
Ø\[® íÅ©Ãâ|^ám.   
 Ö>çª ØkºïV«D ØkFØ>MÐD ¼åVF yìÂzD ¨[Å ¶½BV_ 
cð«éVD.  c^ÓÂzÂ ØïV|Âï, Ö>uzÂ z¹ìßE cõ¦VÂzD  
ØÄFçï¥D, E®Àì ØÃòÂþß ØÄFçï¥D, òm cõ¦VÂþß  
ØÄFçï¥D cç¦Bm. 
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External  :  Ä\ªïVö 
    c¦_¼>u¤ 
    ¶¿ïéïu¤, mkì©¸.  
ØÃVmzðD 
 ØÄV¤ Aç¦ ØBõz[\åç\ ¼ÄVöBVÄD 
 Ã¤þ«ïè ï_KªD Ã[¼ªVF ‡ Øå¤çBÝ 
 >¦ºïðºï Ãºþòt Äì©Ãs¦Þ ÄÍ] 
 l¦ºïªº ïéÂþu¼ÃV Ø\õ. 
ØÃVò^ 
á ØkºïV«Ý]ªV_ >kçáßØÄV¤ Aç¦, ¨õkçïÂ z[\D,]ª¡,
Ö«Ý>JéD, Î¿ÂzÂ þ«ïè ¶ß\ö, ÃºzkV>D, Ã_¼åVF,  
åVákaçBÝ >|Âþ[Å JÝ]« þößÄ«ºï^, ïÃV]ÂïD, A¿,  
ÃVDA x>oBçkï¹_ cõ¦VzD.  åÞ·, ÄÍWÃV>D x>oB  
¼åVFï^ ÀºzD ¨[Ãì. 
á ØkºïV«D ïÃÝç>¥D, Àì©¸èçB¥D ÀÂzD, \u®D Öm  
\Í>©¸«ÄkD, kVFs«ðD, xçéÂïVDA s«ðD, ó>ï©ÃVõ|, 
ó>ïÂïâ|, gï\óçé, ØÃòDÃV|, ÀìÂ¼ïVçk ïVÂçïko,  
¸«Äk ¶]ÄV«D x>oB ¼åVFïçá¥D ¼ÃVÂzD.  Ö>çª      
\Í>© ¸«Äk ¼k>çªl_ ïò©çÃçBß ·òºïß ØÄFB        
ØïV|ÂïéVD. 
      ‡ E. ïõbÄVt ¸^çá 
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ïV« ÄV« ékð kçï 
 kwçé åu ¯À® åkÄV«D ¨kÄV«D 
  kçá¥©A ØïÍ]¥©A  
 kVïV« ØkºïV« x¦¼ªïD ÃßÄV«D 
  kVöåç« ¶xö¥©A 
 >wéVò ïu¯«D cBìÃßçÄ ïu¯«Í 
  >ºz Aïµ ÄÝ]ÄV«D 
 >çï¼\¡ Øk½¥©A *ªDÃì ØÃV[ªDÃì 
  >ç«¼\¡ Ä¡â|ékðD 
 ïw®åu ¤éé¡ð tÍm©A EÍm©A 
  ï_K©A ïVEÄV«D 
 ïVbD¸ ÃVékðD ¶â|©A æªtª¡ 
  ïòmåu ïV« ÄV« 
 ¶wïVª ékðÝ][ kçïØB[Å ïu¼ÅVìï^ 
  ¶çÅkVìï ákM °ÝmD 
 ¶öBzò åV>çª B|Ý]ku ¤[ØÄB¼é 
  g«VFÍm ØÄV_K¼kV¼\ 
ØÃVò^ 
 kwçé, ¯À®, åkßÄV«D, ¨kßÄV«D, kçáBK©A, ØïÍ]B©A,  
ØkºïV«D, °ïVDÃ«ßÄV«D, ï¦_Oç«, ¶xö¥©A, ïu¯«D, ÃßçÄÂ 
ïu¯«D, ÄÝ]ÄV«D, Øk½¥©A, *ªDÃì, ØÃV[ªDÃì, Ä¡â|©A, WéV 
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c©A, ÖÍm©A, EÍm©A, ï_K©A, ïVEßÄV«D, ¸¦VékðD, ¶â|©A,  
æªD gþBkuçÅ ïV«ÄV« ékðkçïØB[® í®þ[Åªì. 
ïV«ÄV«D 
  ÖBuçï c©A  ‡ 10   
  ØÄBuçï c©A  ‡ 15. 
ÖBuçï c©A 
 ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
  ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ ¸ÅÂþ[Å ïV«ÄV«D 
 Ãò]¼B ÃÝmkçï© ÃõçÃÂ ¼ïÓ 
  ÃVºïVª ó¦ØªV| æªÍ>VÐD 
 kò]¼B ¯À® kçáBK©A 
  \ð\VzD ÃßçÄÂïì©¯« \VzD 
 Aò]¼B ï_K©¯Â ï¤¥©¼ÃV| 
  ØÃV[ªDÃì *ªDÃì Oç«¥ \V¼\  
        ‡ ¼ÃVïì ‡ 2000  
ØÄBuçï c©A 
 ¶çÅÍ]â¼¦[ ïV«ÄV«Ý][ çk©çÃ 
  ¶¦ºïéVF JkÞÄ >[çªÝ >VÐD 
 >Âï¼k ïV«ÄV «Ý][ çk©Aß 
  ÄJÄBºï ¹_éV\_ JçkÍ >VzD. 
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ØkõïV« ·Ý] 
 ØkõïV«Í >V[ ØÃVöÝm ¼\u¸ÂÄÞ ÄVuÅV_ 
 >[ ïV½ BV>_ >MÝ>ç«Ý>_ ‡ Ãõ ·Ý] 
 ïu¯«Ý][ #çáÂ ï«õ½loâ¦V ØåFsâ 
 Ø¦V©ÃØk¿ ØÃVºï ØköÝm. 
    ‡ ¶ïÝ]Bì çkÝ]B EÍ>V\è : ÃÂïD ‡ 326 
1. \õ 
2. ïuÃV>Ý][ 
3. ï«õ½loâ|¸[ 
4. ØÃVº¼ïØwöÝm 
ØkõïV«Ýç> ØÃVöÝm ¨KtßÄD ÃwßÄV®, ïV½ Öku¤_ ¶ç«Ým  
¨|Âïß ·Ý]BVzD.  ïu¯«Ýç> ØåFl_ sâ| ØÃVºï ¨öÝØ>|Âï  
·Ý]BVzD. 
 
Äì¼k·« «ÄD 
 ØkõïV«D ÄV]oºïD ¼\é« t«>ïÍ>D 
 ÎõïVð åV¸ WçÅ ¼BVç«Ím ‡ ¶[ÃVF 
 ØïV½¼ko ØkÍ>Àì íâ½Bç« z©¸¥^¹_ 
 ¶ç¦so| \õ æçé gFÍm. 
 gFÍ>\õ æçéØÄFm gu®\ðØéÍ]«Ý][ 
 °FÍ> sòÄV\ Ø\ölâ| ‡ ÎFÍ>¸[A 
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 z[¤Básâ¦V_ ØïV½B·«D ¼>V¦D¼ÃVD 
 Øk[¤Äì ¼kÄ«D ¼Ãì s^. 
¼ÄòD Ä«Âzï^ 
 ØkºïV«D, ÄV]oºïD, Ö«ÄD, ïÍ>ïD, åV¸ (Ä\ ¶á¡) 
ØÄFxçÅ 
 ØïV½¼koÂ z½Àö_ ¶ç«ÝmÂ z©¸loâ| æçé\õ ØÄFm,  
kVKïVBÍ]«Ý]_ Öò ÄV\D ¨öÝØ>|Ým g¤B¸[ ¶ç«ÝmÂ  
ØïV^á ¼kõ|D. 
yòD ¼åVF    
   ·« ¼>V¦D 
T« sÂþ«\ «ÄD 
 ¨â½sç« åVs Ö«>D ÖÍm©A ÃV>«ÄD 
 ïâ½© ØÃòºïVBD ØkõïV«D ‡ Îâ½B¼>Vì 
 ]©¸oJ éÝ]ØªVò ¼Ä«sâ| ¼åìØÃV½BVBVF 
 ØÄ©AÀì ]©¸o JéD ¼Äì. 
 ¼ÄòD þÄVBÝ][ ØÄöÍ#Ä_ ÖâØ¦öÝm 
 gÅ¼k ÃõèB>[ ¸ß·ß ‡ ¼Ä«kç«Ý 
 mõbz[¤ \VÝ]ç«l_ ¼>V¦·«D ¼ÃV|D 
 cõbT« sÂþ«\D Îì.    
    ‡ ¶ïü]Bì çkÝ]B EÍ>V\è ‡ 1092 
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¼ÄòD Ä«Âzï^ 
 ¨â½sç>, åV¸, ÖÍm©A, ÃV>«ÄD, ØÃòºïVBD, ØkºïV«D,  
]©¸oJéD (Ä\ ¶á¡). 
ØÄFxçÅ
 ÖkuçÅ ]©¸oJéÂ z½Àö_ méVBÍ]«\Vï ¨öÝm g¤B¸[ 
Ã[¤© ¸ß· ¼ÄìÝ>ç«Ým z[¤Bá¡ \VÝ]ç« ØÄFm ØïV^á  
¼kõ|D. 
yòD ¼åVF    
   ¼>V¦·«D 
·Ý] xçÅ (¼k®) 
 Ö>çªÂ þµïâ½, ¨òç\ß ÄVðÝç> Àö_ ïç«ÝmÂ ØïV]Âï 
çkÝm, ¶]_ ïaçk ¶¿Ý] ¶¿Ý] ¨|Ým ·Ý>Àö_ ï¿s óöB 
Øk©ÃÝ]_ céìÝ>ß ·Ý]BVzD. 
 ØkºïV«Ýç>ß æçél_ x½Ím ¨òç\ßÄVðÝ]_ ØÃV]Ým  
çkÝm, 3 åVâï^ ØÄ[Å¸[ ·Ý> Àö_ ï¿s céìÝ>ß ·Ý]BVzD. 
1. Ã·s[ ÄVð©ÃVo_ Ö>ç>Â ï¿s céìÝ>ß ·Ý]BVzD.   
 ¨òç\ JÝ]«Ý]_ Öç> 3 åVaçï »ÅçkÝm ¨|Âïß        
2. ·Ý]BVzD. 
3. Ö>çªß Äâ½loâ|© ØÃVöÝmÂ ïV½léVkm ÃwßÄVu¤éVkm 
 ¶ç«Ým céìÝ] ¨|Âïß ·Ý]BVzD.  Ö>çª Àìku®DÃ½    
  ØÃVöÝmÂØïVõ¦V_ ·Ý].  
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4  ÃwßÄVu¤éVkm ¶öEÂ ï¿ÀöéVkm ¶ç«Ým céìÝ]Â       
  ØïVõ¦V_ ·Ý]. 
5.    ÃwßÄVu¤éVkm, ïV½léVkm,ØåVßElçéß ÄVu¤éVkm        
  çkÝmÝ mçkÝm céìÝ]ªVKD ·Ý]BVzD. 
\òÝmk ÃB[ï^ 
" Îò k«VïØªç¦ (4.2þ) ØÃVöÝ> ØkºïV«Ýç> ïVFßE xöÝ>  
¼>[ 1 ÃéÝ]_ (35þ), ïéÍm kVl_ Aõ, ¶Âï«D Öçkïâ|Ý
>¦k zðÝç>Â ØïV|ÂzD.  Ö>uz "ØkºïV« \m" ¨[Ãm  
ØÃBì. 
" ØkºïV«Ýç>© ØÃVöÝm ØåF ¶_ém ØkõØðF zçwÝmÝ 
>¦k, c>| Øk½©A, kVFs«ðD, åV©Aõ Öçkï^ g®D  
¼>ïD z¹òD. 
" ØkºïV«D ÃéD Î[®Âz 33þ«VD, ¨â|©A Àì sâ| ïéÂþÂ  
ØïV^á¡D.  Ö>uz ØkºïV« Àì ¨[Ãm ØÃBì.  Ö>çª kVF 
Aõ, Ø>Võç¦©Aõ, Ö«Ä¼kÂïVáD, ¶Âï«D x>oB ¼åVF 
ïáV_ kVFØïV©Ã¹©Ã>uzD, Aõ, gÄª Øk½©A, ÖçkïçáÂ
ï¿¡k>uzD cÃ¼BVþÂï zðÝç>Ý >òD. 
" ØkºïV«D 1 k«VïØªç¦çB 1/8 gwVÂz (21 t.o) Àö_  
ïç«Ým, xçéÂïVDA, Øk½©A, Aõ ÖçkïÓÂzÝ mèl_  
åçªÝm ¼\KÂz© ¼ÃVïÂ zðxõ¦VzD.  zwÍç>Âz© ÃV_,
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ØïV|ÂzD ØÃV¿m ü>ªÝç> å[ÅVïÂ ï¿s ØïV^á  
¼kõ|D. 
" ØkºïV«D 1 k«VïØªç¦çB (4.2þ) 1/8 gwVÂz (21t.o) Ã[¤ 
ØåFl_ ïéÍm, ko¥¦[ í½B JéÝ]uz© ¼ÃV¦Â  
zðxõ¦VzD. 
" ØkºïV«D 2 k«VïØªç¦ (8.4þ) 11/2 gwVÂz (252t.o) Àö_  
ïéÍm ¸«¼\ïD, ØÃõïÓÂzÂ ïVbD ïì©Ã ¼\ïD,  
ÖçkïÓÂz© ¬ßÄÂ zðxõ¦VD. 
" 4 k«VïØªç¦ (16.8 þ) ØkºïV«Ýç> 1 gwVÂz Àö_ ïéÍm  
ÀìÝ mkV«Ý]_ cõ¦VzD ¨ößÄKÂï© ¬ßÄ¡D. Ö«Ý> Äì\  
¼åVF, ØïV·Âï½, ¼kìÂzò gþB ¼åVFïÓÂz Öç> ¼\KÂz
¼ÃV¦ zðxõ¦VzD. 
ØkºïV«D ¼ÄòD \VÝ]ç«ï^ 
¸«\VåÍ> Ãl«k \VÝ]ç« 
kÄÍ> z·\Vï«D \VÝ]ç« 
 kõ¦ºïð \é«D ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
 ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
 ¶bþ ¦V]ç> B[ ¼ÃV|õð¼k 
       ‡ EÝ> çkÝ]BÝ ]«â|. 
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¼ÄòD Ä«Âzï^ 
9 ÖoºïD 
9 ØkºïV«D 
9 ÖékºïD 
9 ]©¸o 
9 ¼ïVi¦D 
9 ¶Âþ«VïV«D 
 
9 ¶]\m«D 
9 ¼ïV¼«VÄáD 
9 zºz\©¯ 
9 ÃßçÄÂ ïì©¯«D 
Öçkïçá xçÅ©Ã½ ·Ý]Ým ï_kÝ]oâ| ØÃV½Ým ÖÞEßÄVu¤_
Ö«õ| åVÓD, xçé©ÃVo_ Ö«õ|åVÓ\Vï å[ÅVï ¶ç«Ým ÃM©
ÃBÅá¡ còâ½ WwoKéìÝ>¡D. 
¶ÐÃVªD    
   >Âï ¶ÐÃVªD 
yòD ¼åVFï^ 
   ·«ºï^, ïÃïVÄD, 
   >VïD, E®Àì ¼åVF, mD\_. 
 
kçïÂz Îò k«VïØªç¦ 
kçïÂz 1/4 ÃéD 
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1. s¼«Äª ¯Ã] \VÝ]ç« 
2. ØkºïV« \VÝ]ç« 
 ØkõïV«xÞ E®]©¸o táþÍ>m ·Âz 
 ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
 ¼ïáVBâ¦ z[\Þ óçé ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
 ïVáVºïDA^ ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
       ‡ EÝ> çkÝ]BÝ ]«â|. 
ØÃVò^ 
¼ÄòD Ä«Âzï^ 
# ØkõïV«D, ]©¸o, táz, ÖÍm©A, ·Âz, ¼åìkVáD, ïVÍ>© 
ØÃV½, ØÃòºïVBD, ïwuE©Ãò©A, 
ØÄFxçÅ 
 Ä«Âzïçá ·Ý] ØÄFm ï_kÝ]oâ| ØÃV½Ým Àìsâ|  
¶ç«Ým ¼ïVa©A¦D ¼ÃVâ| ¨|Ým, ï_kÝ]oâ| ï|ÂïVFÂ z½ 
ÀöªV_ ¶ç«Ým còâ¦¡D.  EÅ¼>uÅV[sç> ¶á¡ \VÝ]ç«  
còâ¦ ¼kõ|D. 
¶á¡ : 1 \VÝ]ç« 
¶ÐÃVªD : ¨õØðl_ ¼>VFÝm ¶òÍ> \éD ïa¥D. 
yòD ¼åVFï^ 
   ¨õkçïÂz[\D 
   ¶õ¦kV>D 
¼>M_ >«¡D 
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ØkºïV«© ÃuÃºï^ 
1. Ã½ï ØkºïV«© ÃuÃD 
 Ã½ï ØÃV½ØBVò ÃVõ¦Ý ]â|Â 
  ï½mÀì ØÃF>ç>Â ïéÂþ å[ÅVF© 
 Ã½ï ÃVõ¦DkVF Ã¦VD söÝ >>M_ 
  k½Ým Ø\_oB kÝ]« J½ 
 ØkFl_ A¦t¦ Økõç\BVFÂ ïâ|D 
  çÃB¼k B>çª© Ã½B zaÂïo_ 
 ¶õ¦Økõ ïòkV éVâ½ò ÄV\D 
  Ãõè| s_çé Ãïék ØªV¹lu 
 ïVFÍ>¸[ ¼ïVaÂ ïªéA¦ \Vu¤ 
  kVFÍ> Àu¤çª kçïBV l[kðD 
 nDxçÅ ØÄF>¸ ªtì>\ >Vz 
  \òÍ Ø>Vò\Þ ÄV½lªákVF 
 Ã·s[ ØkõØðFØåF ÃV¦Vð ¼Ã] 
  Àìx^¹ ¥ÞE® ØåòÞE lçkï¹[ 
 ‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡‡ 
  xçÅ¥¸ à>VØ\ª Ø\VaÍ>m \V¼\.  
       ‡ EÝ> çkÝ]BÝ ]«â| 
¶ÐÃVªD  : E®¬çáÄV®, E®ØåòÞEßÄV®  
¶á¡  :   z[¤ ¶á¡  
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yòD ¼åVFï^  
   ÀìÂïâ| 
   Äç>Bç¦©A 
   ÀØ«ö¡ 
ØkºïV«© ÃuÃD 
¶á¡ : z[¤ ¶á¡ 
¶ÐÃVªD : ÃV_ 
yòD ¼åVFï^ 
   Øk©Ã© ¸èï^ yòD. 
1. ØkõïV«© ÃuÃD 
 ØkõïV«D 11/2 ÃéD, (521/2þ), Øk^çá©¯ ¯Âþ[Å ïVEÝ 
mDçÃ, ÖçéßÄV® ØÄ_éÝ>Âï ¶á¡. 
ØÄFxçÅ 
 ·Ý] ØÄF> ØkõïV«Ýç> ï_kÝ]oâ|© ØÃV½Ým ¼\uïõ¦ 
ÄVuçÅ E®ï E®ï kVìÝm ÎòÄV\D (3\è), ¼å«D ¶ç«Ým© ¸_çé
ØÄFméìÝ] Îâ½oâ| ¼\¼éV| J½ J[® æçé\õ ØÄFméìÝ]Â 
ïkÄÝ][ ÃÝmº ÃºØïç¦ k«Vâ½lu A¦tâ¦V¤ª ¸[Øª|Âï©     
ÃuÃ\VþlòÂzD. 
¶á¡  : 4 x>_ 7 z[¤\è ¨ç¦. 
mçð \òÍm : ØåF, ¼>[, ØkõØðF, x>oBçkïáVD. 
yòD ¼åVFï^ : ¸Ý>¼åVF ¨_éVkçï¥D yòD. 
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ØkõïV«ß ·õðD 
 åVâ|ØkõïV«D ¼>çkBVª ¶á¡ c©¸éVº ØïV½ß  
ÄJéßÄV® ØÄ_éÝ>Âï ¶á¡, xòºçï©Ãâç¦ ØÄ_éÝ>Âï ¶á¡. 
ØÄFxçÅ 
 ØkõïV«Ýç> Îò ¬ºïV[ ÃVÝ]«Ý]u¼ÃVâ|, ¶m Ö«õ¦º 
zéD gµÍ]òÂzDÃ½BVï ¼\uÃ½ ÄVuçÅsâ| J[®åV^  
ØkFlo_ çkÝm ¶_ém ÄVØÅ_éVÞ ·õ|þÅ kç«l_ Øklo_ 
çkÝmß ÄV® ·õ½ª ¸[ xòºçï©Ãâç¦çB ØkõØðF ¼ÃVé 
ç«Ým  ¶>uz^ ¼\uÃ½ ØkºïV«Ýç> çkÝm© ØÃV]B ¼kõ|D. 
ïkÄ\Vªm ØkõïV«Ý][*m Îò ¶ºzé ïªtòÂï ¼kõ|D.   
ØkFléìÝ]  å[ÅVï céìÍ> ¸[A ¶>[¼\_ °¿ æçé\õ ØÄFm
éìÝ] nDÃm  ÃéD k«â½lu A¦tâ¦V¤ª ¸[ ¨|Âï ·õð\VF 
ÖòÂzD. 
¶á¡  : 2 x>_ 4 z[¤\è ¨ç¦. 
mçð \òÍm : ¼>[, ØåF, ØkõØðF, ÖáÀì. 
yòD ¼åVFï^ 
   À«ç¦©A , Äç>Bç¦©A,  
   ï_éç¦©A gþBçkï^ yòD. 
 
 
 
44 
 
ØkõïV« Ø\¿z 
ØÄFxçÅ 
 ØkõïV«Ýç>ß ·Ý] ØÄFm ØÃV½Ý>Â ï«õ½l_ ¼ÃVâ| E® 
¶D\V[ ÃßÄöEß ÄVuÅV_ E®ïßE®ï ·òÂzÂ ØïV|Âï¡D. ÖËs>D
·\Vì Îò ÄV\D ØïV|Ý>V_ Ø\¿ïVzD.  Ö>çª© ¬ºïV[ Etµ  
¶_ém ØïVDAß Eta_ ÃÝ]«©Ã|Ý> ¼kõ|D. 
¶á¡  : 4 x>_ 5 z[¤\è ¨ç¦. 
yòD ¼åVFï^ 
   À«ç¦©A,  
   ÀìÂïâ|, gþBçkïçá yìÍm 
   c¦_koç\, c¦uïâ| x>oBçkï^ cõ¦VzD. 
 
ØkºïV«D ¼ÄòD ØÄÍ#«ºï^ 
1. g®xïß ØÄÍ#«D 
ØÃVò^ 
 Ö«ÄD 5 ÃéD, ïVÍ>D 7 ÃéD, ïÍ>ïD 9 ÃéD, ØkºïV«D 8 ÃéD
ÖÍm©A 4 ÃéD, ¶B©ØÃV½ 12 ÃéD, ÖçkïçáÂ ï_kÝ]oâ|Ý >M
Ý>M© ØÃV½Ým, xçÅ©Ã½ ïéÍm ¶ç«Ým, ïuÅVçw©ÃV_ ¼ÄìÝm  
å[ÅVï cÅkVzDÃ½ 5 åV^ ¶ç«Ým, s_çé >â½Â ïVBçkÝm,  
¶ï[Å Äâ½l_ çkÝm, kVF ØÃVòÝ>\Vª \uØÅVò Äâ½l_ J½ 7 
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æçé\õ k[ç\BVFß ØÄFm, ¨â|ßÄV\D ¶|©¸oâ| ¨öÝm, g¤ª
¸[ ¨|Ým© ÃVìÂïß ØÄÍ#«D \VmáD¯ WÅD ØÃu¤òÂzD. 
¶á¡ : ÃðØkç¦ 
¶ÐÃVªD : ]öï|zÝ#^, ¼>[, 
yòD ¼åVFï^ 
   ¶®kçï JéD,  
   ¨öz[\D 
   ÃVõ|, ¼ÄVçï,  
   ¶]ÄV«D. 
2. ï¡ö EÍ>V\èß ØÄÍ#«D 
Øk½¥©Aß ·õðD 
 ¶®kçïß ØÄFÀì Îò ÃéØ\|Ým, ¶]_ ØkºïV«D ØÃVöïáV_
ÃéxD, Ã½ïV«D ØÃVöïV_ Ãéxºíâ½, Îò ¬ºïVM_ ¼ÄìÝm, Îò  
Äâ½l_ 3 ¶ºzéD \ð_ØïVâ½, ¶>[*m ¬ºïVçª çkÝm  
¨öÝmß ·õð\Vª ¸Åz ¨|Ý>© Ã>ªD Ãõð¡D. 
¶á¡ : 1/2 x>_ 1 ¶öE ¨ç¦. 
¶ÐÃVªD : ÖáÀì, x^áºþ. 
yòD ¼åVFï^ 
   ÀìÂïâ|,  
   À«ç¦©A,  
   Àì¨ößÄ_ 
46 
 
Øk¹BVâE \òÍmï¹_ ØkºïV«D 
 
ØkºïV« Àì 
 ØkºïV«D ÃéD Î[®Âz ¨â|©A Àìsâ| ïéÂþÂ ØïV^á¡D 
☯ kVF ØïV©Ã¹Âï¡D. 
☯ AõïçáÂ ï¿k¡D c>¡D. 
 
ØkºïV«© ØÃV½ 
 ÃßçÄ ØkºïV«Ýç>ß ÄVè©ÃVo_ ¼>VFÝmÝ mç¦Ým  
céìÝ] OõèB ØÃV½ØÄFm, AõAç«Aç¦ï¹[ *m #k   
¶ªkï^ \V®D. 
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Øk^çá táz ‡ vellai milagu 
Eng  :  white pepper 
Sans  :  sitha –marieh  
Öm, ïV|ï¹_ káòD Îò kçï \«Ý>]M[® þç¦ÂzD ÃwÝ][   
ØïVâç¦¼BBVD.  ÎËØkVò ÃwÝ]KD Ö«õ| ØïVâç¦ï^ cõ|.   
ÃwD EkÍ> WÅ\V¥D, sç>ï^ Økõç\WÅ\V¥D ÖòÂzD. 
ÃB[Ã|D c®©A  :  sç> 
·çk   :  ïVì©A  
>[ç\  :  Øk©ÃD  
¸ö¡    :   ïVì©A. 
ØÄFçï 
 Øk©Ãxõ¦VÂþ (ciðïVö) 
 ¶ïâ|kVFkïu¤ (c>«kV>Ç«ïVö) 
zðD 
 Ö>ªV_ åVâÃâ¦ ïVFßÄ_, nBk¹·«D, ·«D, ¼\>D Öçk  
¼ÃVzD.  ÃE cõ¦VzD. 
 Øk^çá táïòÍ> T®þ«ïè¼ÃVD 
 >^Ó ïÃkV>Í >V¼ªzD ‡ c^á 
 ·«D ¼ÃVzÍ yÃª\VD Ø>V_¼\ïD ¼ÃVtÝ 
 ]«DÃVì ¨kìïÓÂzÍ ØÄ©A. 
Ö>[ #çá zçkªV¡¦[ ¼ÄìÝm kwºï xçÅß·«D ÀºzD. 
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T.V. ÄVDÃEkD¸^çá íu®©Ã½, Øk^çá táz ¨[Ãm,  Remove 
the outer skin of the black pepper. – Vol. V. 
 ¶öçk¥ÅVÂ ïV« \ç¦Í]òÂzD kV> 
 sáçkØB_ éV\®Âï Ø\F¼B ‡ táþ[ïVF 
 ïõ¦kìÂz t[¦\VF ïVöçï¼B ‡ æµJéD 
 ØïVõ¦kòÂz å[\zÍ>Vº í®. 
     ‡ tz ïVì©Aß ·çk¥ç¦B tázÂïVF æµJéÝç> ÀÂzD. 
táz ·Ý] 
 ØïV½¼ko ¼kìßÄVu¤_ íì ]©¸o çBRÅ 
 k½kVå[ \Vtáþ[ kVì¼\Vç«© ‡ Ã½B¼k3 
 »Åsâ|Ý >VÐéìÝ] Îâ½oá k®©ÃVF3 
 ¼>Åk®ÂïD4 ·Ý] ØÄ©A. 
 táçï ¼\Vö_ »ÅçkÝm céìÝ] Îâ½_ k®ÝØ>|Âïß  
·Ý]BVzD. 
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ÖÞE 
    \mç«ÂïVÞEl_ ÖÞE ï_>ç«l¦Ý¼> zsÂï©Ãâ|^ám  
¨[® z¤©¸|þ[Åm. 
 “ÖÞE \ÞÄ^ çÃºï¤ ¸Å¡D 
 Ã_¼k® >V«¼\V| ï_éïÝm ~õ½”   ‡ \mç« ïVÞE 289 ‡ 290. 
 Ãâ½ª©ÃVçé ÖÞE, ïwMl_ sçákç>Â í®þ[Åm. 
 “x>u ¼ÄD¸[ xçá ÖÞE”          ‡ Ãâ½ªÃVçé ‡19. 
ÖÞE Î«Võ|ßØÄ½.  ¶ï[Å Àõ¦ Öçéïçá cç¦Bm.  ØÃömD 
\ÞÄ^ ØÄ½çB ÎÝ>m.  \ÞÄ¹[ þwºçï© ¼ÃVé ÖÞE¥D ØÄ½Âz
¶½l_ \õè_ Aç>Ím káòD.  ÖÞEß ØÄ½l[ >õ| ¨[Ãm  
ÖÞEÂ þwº¼ï gzD. 
ÖÞEl[ ØÃBì (¶ïÝ]Bì ÃÞÄïVsB Wïõ| 143) 
 ·ï\Vª k®ïV> k_éØ\[®D 
  ïòkVª g>«\VÝmkVï Ø\[®D 
 Ø\>\Vª ¼\éV]ØB[®D ¼Ãò 
  ¼\ïÂ ïòÃV] ØB[®ÃV>uz ¼Ãò 
 t>\Vª \ï«Ø\[¤>uz© ¼Ãò 
  \VªVþ JoØB[¤>uz©¼Ãò 
 å«\Vª å«DØÃ[Å t>uz©¼Ãò 
  åVDØÄV[¼ªVD ÖÞEBV_ å_é© ¼Ã¼«. 
50 
 
¼k®ØÃBìï^ :  ¶_éD,  
gìÝ>«ïD,  
gÝ]«ïD,  
ÖéVÂØïVâç¦,  
å®\®©A \]_. 
káöB_A 
 Öàm ÖÍ]BVs_ ¶¼åï Ö¦ºï¹_ Ãlö¦©Ã|þ[Åm.  Àì  
ØÄa©A^á Ö¦ºï¹_ xÂþB\VF cõ¦VþÅm.  glÐD ØÄDÃV| 
ï¹KD, \ð_ ¯tï¹KD, EÅ©ÃVï¡D, ØÄ[çª, ØïVßE, ]«kVºíì 
x>oB Ö¦ºï¹KD ÃÞÄV©, kºïVáD, x>oB åV|ï¹KD  
°«Vá\Vï¡D Ãlö¦©Ã|þÅm. 
ÃB[Ã|D c®©A : þwºz 
·çk   :  ïVì©A 
>[ç\   :  Øk©ÃD  
¸ö¡   :  ïVì©A 
ØÄFçï 
 ¶ïâ|kVFkïu¤  ‡ carminative ‡  c>«kV>Ç«ïVö 
 ÃEÝyÝ#õ½ ‡ Û¦VÂþkìÝ]M -  stomachinc 
 ctµÀì©ØÃòÂþ ‡ sialogogue  ‡ ]«¡ïVö 
 ØÄö©Aõ¦VÂþ ‡ Digestive  ‡ yÃªïVö 
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 Øk©Ãxõ¦VÂþ ‡ Stimulant  ‡ ciðïVö 
 >½©Aõ¦VÂþ ‡ Rube facient ‡ ¼ÇVðïVö. 
zðD 
 ÖÞElªV_ Öò\_, ~çá, Øk^¼áVÂïVáD, ¶w_zuÅD,  
k¹óçé, xÂzuÅ ¼åVFï^, ¼ïVçwÂíâ¦D, ØÄöBVÂïaßÄ_, Öçk
¼ÃVD ÃE¥õ¦VzD. 
 ÖÞEÂ þwºzÂ þò\_ nBD ÎÂïVáD 
 kÞEÂzÞ Ä[M·«D k[¼Ã] ‡ sÞ·þ[Å, 
 óçéB®D kV>D¼ÃVÍ #õ¦V> yÃª\VD 
 ¼kçé¥®º ïõðVF ‡ sáDA (¶ïÝ]Bì zðkV¦ïD) 
  
 ÖÞEl[ zð¼\ Ø>[¤B_A¦ Oç«Âïº ¼ïCì 
 ¶ÞE|Þ Ä[MØB_éV \ï[¤|D ¸Ý> ¼>V¦D 
 ØåÞEMoò\u ¼ïVçw ØåþµÍ]|D ïÃºï^ >[çª 
 tÞEè kò¼\V Øk[® sáD¸|D ¼>k ±¼é (°|) 
  
 \õèéVÂ ¼ïVâç¦ØBV[® \VÝ]«¼\ ïuÃØ\[Ã 
 Ø>õèÂçï BVþ lòÂz¼\ ‡ ïõbÂz 
 å[xçÅBVÞ æ>áÝç> åV¦V\ ¼éB½ÂzÍ 
 ][xçÅç\ ÀB¤Ím ][. 
 Öàm Îò ïuÃ \òÍm. Öàm ïõïÓÂz åéÝç> ÃBÂzD     
ïÃÂzuÅÝç>© ¼ÃVÂzD. 
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 ÖòÍ¼> ªéºïV« Ø\F>l[® *¤ 
 lòÍ¼> ªéºïV« Ø\F] ‡ ÖòÍ¼>[ 
 Às «ïEB\V Øå[\V ¡¦[ïéÍm 
 Às «ïEB\V ØåF. 
       ‡ ¼>«[ B\ïØkõÃV 
ØÃVò^ 
 ¼>M_, ÖÞEçBÂ ÿu®Â ÿuÅVïÂ ÿ¤lâ|, ¶m å[ÅVF  
»¤ª ¸[A, ¶ç> \ªÝ ]¦Ým¦[ ï_Ã xçÅ©Ã½ cõb>_  
å_ém.  ¶ºôªD cõ¦V_ åç«, ]ç«, J©Aïáu® kVwéVD.  ØÃò
kl® \òÝmkÝ]_ ÖÞEß ÄVuçÅ åVáás_ ïV_ gwVÂïVï  
cBìÝ]Â  ØïVõ¼¦ 11/2 gwVÂz kÍ>¸[ ¶ËkákVï¼k ¼åVF  
ÀºzD \â|D ØïV|Âï ¼åVF yòD. 
ÖÞEß ó«ðD ‡ 1 
]öxu ÃkÝmö ¼ÃVÂþÝ >¤Ø>V½ yÝØ>VçïÝm© 
ØÃöØÃVö ÃÞÄVÍ]MlØéV^ OºïÃÝ Ø>õsÛBD 
ÄöØBöÍ ]â½½ ¥õØÃV½ Js«u ÄÝ]x>_ 
¨ökáì \Í>xD ¸Ý>© ¸è¥ t¦«®¼\. 
¼>V_ ÀºþB ÖÞE ÃéD 40‡nÝmõ| mõ¦VF ¶®Ým céìÝ],  
ØåFlu ØÃVöÝm© ØÃV½BVÂþ, ·Ý]Ý> æ«ïD 20 ÃéÝç> ØÃV[ 
k®kéVï k®Ým Ö½Ým© ØÃV½BVÂþ, ÖËs«õ|D ¼Ä«Í> ¨ç¦  
¶>Vkm 60 ÃéD æM ¼ÄìÝm ¨_éVkuçÅ¥D Î[ÅVïÂ ïéÍm,  
53 
 
Js«_ ¶á¡ ØïV^á kVÍ], c¦Øéö¡, ¶ª_, \Í>D, ¸Ý>©  
¸èï^ yòD. 
         EÝ> çkÝ]BÝ ]«â| ‡ 213. 
ÖÞEß ó«ðD ‡ 2 
ÖÞE¥ x©ÃéÍ>V[ ÖB_ØÃÅÂ ïõ¦\VÂþ 
tÞÄØåF >M_¡ ®Ým táz]© ¸o J[ÅVï 
sÞEB Jé Ø\V[® T®á¼kéÞ ·Âz 
>ÞÄÄV ]ÂïV ¼BV| >VáÄ¦V \VÞE íâ¼¦. 
íâ|æ« ït«õ|D ¼ïVâ¦xÞ E®åVï©¯ 
kVâ½B ékºï© ÃÝ]ö káìØkâ½ ¼kìþ«VDA 
yâ½B ÄV]ÃÝ]ö ]ï¿Í>Vö ÄØ\V[ÅVï 
åVâ|ß ÄìÂ óç«ÃÝ>ïï å¤Bïõ ÃVÝ]öBVï. 
tïï k¼«VÄï tz \õðÝ m¼kVD 
ÃÂïkV¥ Ãòzçé ØBö¡¦[ 
>ÂïkV¥¡D ÄÝ]¥º ¼ïVçw¥D 
yÂïÍ ó«æïV kV¥¡Í yò¼\. 
ÖÞE 3 ÃéD, ]©¬o 3 ÃéD, táz 3 ÃéD, ]©¸oJéD, °éD, ·Âz,
ÄV]ÂïVF, ÄÃV\VÞE_, æ«ïD, ¼ÄVDA, ¼ïVâ¦D, E®åVï©¯,  
Öékºï©ÃÝ]ö, Økâ½¼kì, þ«VDA, ÄV]©ÃÝ]ö, >V¹ÄD kçïÂz  
1 ÃéD, åVâ|ßÄìÂïç« 10 ÃéD, ÄìÂïç« ÀºïéVï \uÅçkïçáß  
·Ý]Ým >MÝ>M© ØÃV½Ým, ¨_éVkuçÅ¥D ÄìÂïç«¥¦[ ïéÍm 
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J[®s«_ ¶á¡ ØïV|Âï ·çkl[ç\, »õØk®©A, ÃÂïkVF¡,  
kVF¡, kVÍ], ¼ïVçw ó>ï kVF¡ Öçkï^ yòD. 
ÖÞE ¼éþBD 
 ÖÞE«ÄD, ïõ¦ºïÝ]ößÄV®, Øå|ÞEßÄV®, x^áºþßÄV®,  
ÃwßÄV® Öçk kçïÂz Ã½ Î[® gs[ ÃV_ Ã½ 2, ÃçªØk_éD  
ÃéD 8, ·Âz, táz, ]©¸o, æ«ïD, °éD, kVFs¦ºïD, þ«VDA,  
>V¹ÄD Öçk kçïÂz 1 ÃéD.  Ã·s[ØåF 1/2 Ã½ ¼>[ 1/4 Ã½  
ÄV®ïçáØB_éVD Î[ÅVD ¼ÄìÝm ÃçªØk_éÝç> ¶]_ ïéÍm  
¶|©¼Ãu¤, ïç¦ß Ä«Âzïçáß ó«èÝm ¶]_ ïéÍm ¨öÝm¼éþB
Ã>Ý]éÅÂþ ØåF, ¼>[ Öçksâ|Â þá¤, ÃVÂïá¡ Öò¼kçá   
cÃ¼BVþÂï¡D. 
yòD¼åVFï^ 
  kV¥, ¸Ý>D, kVÍ],  
óçé, ko, ÄBD,  
 ¶[ªÝm¼k−D,  
 ¨õkçïz[\D, ØÃVò\_ x>oBª yòD. 
ÖÞEÝ ]«VkïD 
 å_élÞE >çªØB|ÝmÝ #Âz Î[® 
  åV½l| AçïÀò ¶>M_Ø«â½ 
 ØÄV_olç> åV^J[® A¹ÂïçkÝm 
  óâ½Bç> kVçélâ|© AçïÀìkVºz 
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 Ø\_ékç> lòïV· lç¦¼B ØïV^á 
  ¼\][l_ \VM¦ìÂz cwçé>VïD 
 ØïV_ékÍ> cÃVÄxÞ ·«ºï^ ¼ÃVzD  
  í¤ªVì BV¼ïVA zðt >V¼\. 
     ‡ BV¼ïVA çkÝ]B EÍ>V\è ‡ 237  
Îò #Âz å_é ÖÞEçB ¨|ÝmÂØïVõ| ¶ç> x[ í¤B Açï 
Àö_ Ö½Ým©¼ÃVâ| J[®åV^ A¹Âï çkÝm kVçél_ °u¤Ý  
]«VkïD ÖÅÂþ Ö«õ| ïVØÄç¦ T>D câØïV^á ØåÞ· ¨ößÄ_, 
klu¤_ cÃVÄD, ·«ºï^ x>éVª ¼åVFï^ yòD. 
kwÂz 
 ÖÞEÂ þwºçï »®ïVF, ¼>ûÅ_, Øk_é©ÃVz »Å_ Ãwß 
ÄV® »Å_ ¨ª ÃékçïBVïß ØÄFm câØïV^Ókmõ|. 
xçÅ 
 ÖÞEßÄV®, ¼>[ ¼ÄìÝm ¼>[ ¼ÃVé© ÃVz ØÄFm zºz\©¯, 
°éD, ÄV]ÂïVF, þ«VDA ÖkuçÅ© ØÃV½ ØÄFm #sÂ þá¤  
¨|Ým å[ÅVïß ·Ý>D ØÄF> ïõðV½ ÃVÝ]«Ý]_ çkÝm   
1 ·õç¦Bá¡. 
 ÖÞEßÄV®, \VmáD¯ßÄV®, ¼>[ Ä\¨ç¦ ïéÍm ¼kçáÂz 35
 t.oâ¦ì T>D ÄV©¸â|k«,  ~çá, Öò\_ ÄVÍ]BVzD. 
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 ÖÞEßÄV®, ~«ØkºïVBßÄV®, ¨KD¸ßÄDÃwßÄV®, ÖDJ[®D 
Îò WçÅBVï ïéÍm, ¼kçá 34þ«VD, 2 ¼kçá 3 åVâï^     
ÄV©¸¦ Öç«©A, Öò\_ ¼ÃVD. 
 ÖÞE, Ekç>, æÍ]_, WékVçï, ØïV|¼ko, ïwuEÂØïV½,   
x¦Âï®Ý>V[, xÂï|z, ¯õ| kçïÂz 34 þ«VD ¨|Ým,     
EuÅV\ðÂz ¨õØðF Ã½ ¶ç«l_ ¶ç«Ým, ïéÂþ, ïVFßE 
k½Ým ¼kçáÂz cßEÂï«õ½ T>D ØïV|Ýmk«, k¹z[\D 
yòD. 
 ÖÞEçB ÃVoéç«ÝmÂ ïw¤EÂïVBá¡ 18 t. oâ¦ì ÃVo_   
ïéÍm ïVçé, \Vçé ØïV|Ým k« Öò\_, Öç«©A, z[\D,  
\BÂïD, ¶w_kVF¡ yòD. ÃE cõ¦VzD. 
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MODERN ASPECT 
ACONITUM  FEROX 
Distribution : Himalayan ranges, Grown in the gardens for its 
    showy flowers. 
Common name : Monkshood, Bluerocket, Mithazahar mithavish, 
    (mitha = sweet, zahar and vish – poison) 
Botanical name : Aconitum nepellus 
Toxic parts  : whole plant is poisonous.  However, roots are 
    commonly used.  Roots are conical, tapering 
    and wrinkled (5-10cm long) 
Toxicology 
 In a few minutes after the introduction , of a poisonous dose of 
aconite, marked symptoms supervene.  The Intial signs of poisoning are 
preferable to the alimentary canal.  There is a sensation of burning, 
tingling and numbness in the mouth and burning in the abdomen.  Death 
usually supervenes before a numbness effect on the intestine can be 
observed.  After about an hour there is severe vomiting.  Much motor 
weakness and cutaneous, sensations, similar to those above described 
soon follow.  The pulse and respiration stability fail, death occurring 
from asphyxia. 
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Chemistry   
 The active principle of Aconitum. Aconitine, empirical formulae 
(C33 H45 NO13 ) pharmacology of aconite and aconite first stimulates, and 
later paralyses the nerves of pain, touch and temperature if applied to the 
skin, broken or unbroken, or to a mucous membrane, the intial tingling 
therefore gives place to a long-continued, anaesthetic action.  Taken 
internally aconite acts very notably on the circulation, the respiration and 
the nervous system.  The pulse is slowed, the number of beats per minute 
being actually reduced, under considerable doses, to forty, or even thirty, 
per minute.  The blood-pressure, synchronously falls, and the heart is 
arrested, in diastole, immediately before arrest the heart may beat  much 
faster than normally. 
 The respiration becomes slower owing to a paralytic action, the 
respiration being arrested before the action of the heart.  Aconite further 
depresses the activity of all nerve-terminals, the sensory being affected 
before the motor. 
Alkaloids of Aconitine 
Four new alkoloids 
¾ 15-deacetylnakoganavine, 
¾ Palmadine 
¾ Palmasine and 
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¾ 6 acetyltheteratissine. 
Isolated along with vakoganavine, heteratisine, isoatisine and hetidine. 
Uses 
9 The root be specially prepared before use. 
9 The tough horney material is soaked in either urine or milk from 
the cow and exposed to the sun until it becomes so soft as to be 
easily pierced, by a pin.  The process requires three or five days 
and the urine or milk has to be renewed every day. 
9 Tincture of Aconite at first slows the heart rate.  Lowers the blood 
pressure, and increases the peripheral circulation.  Later the heart 
rate is accelerated and the Bp is raised after treatment of the root, 
with cow’s urine the tincture increase the rate and systole of the 
heart, the blood pressure and the peripheral circulation, and the 
effects of persist for a very long time. 
9 The root either alone or in combination with other drugs, has been 
much recommended for the treatment of snake bite and scorpion 
sting. 
9 In fever, diarrhea, of children cough, asthma, diabetes, nervous 
disease, spermatorrhoea and locally in neuralgia, rheumatism and 
guinia worms. 
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Therapeutics 
 The indications for its employment are limited, but definite.  It is of 
undoubted value as a local anodyne in sciatica and neuralgia, especially 
in ordinary facial or trigeminal neuralgia.  The best method of 
application is by rubbing in a small quantity of the acobitine ointment 
until numbness is felt but the costiliness of this preparation causes the 
use of aconite liniment to be commonly resorted to.  This should be 
painted on the affected part with a camel’s hair brush dipped in 
chloroform, which facilitates the absorption of the alkaloid.  Aconite is 
indicated, for internal administration, whenever it is desirable to depress 
the action of the heart in the course of a fever, formerly used in every 
fever, and even in the septic states that constantly followed surgical 
operations in the pre-listerian epoch, aconite is now employed only in 
the earliest stage of the less serious fever’s such as acute tonsillitis, 
bronchitis and notably, laryngitis.  The extreme pain and rapid swelling 
of the vocal cords with threatened obstruction to the respiration that 
characterised acute laryngitis may often be relieved by the sedative 
action of this drug upon circulation. 
 There is one condition of the heart itself in which aconite is 
sometimes useful. 
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 Will its absolutely contra-indicated in all cases of valvular disease, 
it is of  value in cases of cardiac hypertrophy with over action. 
 But the practitioner must be assured that neither valvular  nor 
degeneration of the myocardium is present. 
Toxic principle 
 Aconite has an alkaloid, sparingly soluble in water and is known as 
aconition.  It is a most virulent poison, with a sweetish taste.   Other 
alkaloids present in small quantities are, 
♣ Picraconitine 
♣ Pseudoaconitine and 
♣ Aconite. 
Action 
 Aconite produces initial stimulation, followed by depression of 
myocardium, smooth and skeletal muscles, central nervous system and 
peripheral nervous system. 
Routes of Absorption 
 Aconites are absorbed via skin and oral route. 
Signs and Symptoms 
♣ Tingling and numbness in the lips, mouth, tongue, pharynx. 
♣ Salivation, pain in stomach and vomiting. 
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♣ Tingling and numbness extends all over the body followed by 
profuse sweating impending paralysis. 
♣ Eye-difficult vision due to hippus which means alternate, 
dilatation and constriction of pupils, initially followed by 
complete dilation, later on. 
Convulsions, ventricular fibrillation and respiratory paralysis usually 
preceds death. 
Background 
 The word aconitum comes from the word “aknoe” meaning 
“rocky” which is the type of area where the aconite plant grows cured 
aconite preparations have a long history of use in Chinese medicine.  
Processed aconite was used to treat heart failure and other heart diseases.  
However aconite has been repeatedly associated with cardiovascular, 
(heart) adverse events.  For this reason, the German commission E does 
not recommend it, use. 
 Aconite is well known for its extreme toxicity, the tuberous root is 
used in traditional medicine, although all parts of the plant are 
considered to be toxic.  Aconite historical usage as an arrow poison and 
as a poison in executions,homicides, and suicides.  Aconoite is also said 
to be an ingredient of flying “uniment” used by witches to imitate the 
sensation of flying. 
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 Aconite has been used in very low doses to treat neuralgia (nerve 
pain) sciatica, and rheumatism.  Aconite is also an ingredient in 
homeopathic preparations used for cold and flu symptoms.  Heart 
palpitations with anxiety acute, inflammatory illness, and peripheral 
nerve pain.  Overall, the efficacy has not been established. 
Aconite 
 A genus plants belonging to the natural order Ranunculaceae, the 
butter cup family.  Commonly known as aconite, monkshood or 
wolfshnae, and embracing about 60 species, chiefly natives of the 
mountainous parts of the northern hemisphere.  They are distinguished 
by having one of the five blue or yellow coloured sepals, in the form of a 
helmot. 
WARNING 
 The blow uses are based on tradition, scientific theories, or limited 
research.  They often have not been thoroughly tested in humans, and 
safely and effectiveness have not always been proven.  Some these 
conditions are potentially serious, and should be evaluated, by a 
qualified health care provide.  There may be other proposed uses that are 
not listed below. 
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Dosing 
 Adults (18 years and older) 
 There is no proven safe or effective dose for aconite.  Topical 
(application on the skin) use is not recommended; Aconite is sometimes 
used in liniments rubifacients with belladonna.  Historically, a 1.3% 
aconitine topical, liniment has been used. 
 Taking 1-5 drops of  a tincture of the fresh, leaf by mouth four 
times a day to relieve pain has been used. 
Allergies 
 Aconite is highly toxic and is not safe for human consumption. 
Side effects and Warnings 
 Based on widespread use, many experts believe aconite to be 
unsafe even in recommended amounts in otherwise healthy individuals.  
Aconite is not recommended for children because of known toxic effects.  
However, homeopathic preparation, containing aconite, has been studied 
in infants with no toxicity reported.  Severe poisoning has been reported 
after ingestion and aconitine(found in aconite) or processed and cured 
aconite.  Aconite is not approved by the German commission E class 3 to 
be used by under the supervision of an expert qualified in the appropriate 
use of this substance. 
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 Aconite may cause hypotension low blood pressure, irregular 
pulse, various arrhythmias (altered heart beats) or first-degree heart 
block.  Aconite poisoning can cause prolonged repolarization of the 
myocardium, which leads to triggered automaticity and veutricular 
tachyarrhythmias, including ventricular ectopy.  Ventricular tachycardia 
(fast heart beat), and ventricular fibriliation.  Aconite has also been 
reported to cause nausea, vomiting, epigastric pain, diarrhea, muscle 
cramps, retrosternal discomfort, dizziness, vertigo, variations in 
motor/sensory skills of limbs.  Ataxia closs of (co ordination) paresthesia 
(altered sensation) “stiffness” in face, trunk and limbs. Clonic 
convulsions, coma, Leukocytosis, (high white blood cell count), dimness 
of vision.  Blackouts, blurred or doublevision, agitation.  
Hyperventiation difficulty breathing, and respiratory depression. 
 In theory aconite may cause liver (or) kidney damage, 
hypersalivation, throat, constriction, hypokalimia (low potasium in the 
blood), and hypothermia, (low body temperature). 
 Tingling and numbness have occurred when aconite is applied to 
the skin (topically). 
 Aconite may lower blood sugar levels.  Caution is advised in 
patients with diabetes or hypoglycemia and in those taking drugs, herbs 
or supplements that affect blood sugar, serum glucose levels may need to 
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be monitered by a health care provider, and medication, adjustements 
may be necessary. 
 Aconite is contra-indicated in patients with coronary disease, 
cardiac dys function, and arrhythmias, or homodynamic instability use in 
patients with suicidal tendencies, due to the abuse potential associated 
with aconite.  Avoid aconite in patents less than 18 yrs, of age due to 
lack of research in this patient, population.  Avoid aconite use in patients 
with gastro intestinal disorders, stomach ulcers, duodenal ulcers, reflux 
esophagitis, ulcerative colitis, spastic colitis, and diverticulosis. 
Pregnancy Breast feeding 
 The use of aconite during pregnancy or heart feeding should be 
avoided since it is known to be toxic even at therapeutic doses.  Studies 
suggest it is unsafe when used orally (taken by mouth) or topically 
(applied to the skin) in pregnant women. 
Toxicological Aspect of Aconitum ferox 
 Aconite has an alkaloid, sparingly soluble in water and is known as 
aconition.  It is a most virulent poison, with a sweetish taste.   Other 
alkaloids present in small quantities are, 
♣ Picraconitine 
♣ Pseudoaconitine and 
♣ Aconite. 
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Action 
 Aconite produces initial stimulation, followed by depression of 
myocardium, smooth and skeletal muscles, central nervous system and 
peripheral nervous system. 
Routes of Absorption 
 Aconites are absorbed via skin and oral route. 
Signs and Symptoms 
♣ Tingling and numbness in the lips, mouth, tongue, pharynx. 
♣ Salivation, pain in stomach and vomiting. 
♣ Tingling and numbness extends all over the body followed by 
profuse sweating impending paralysis. 
♣ Eye-difficult vision due to hippus which means alternate, 
dilatation and constriction of pupils, initially followed by 
complete dilation, later on. 
♣ Convulsions, ventricular fibrillation and respiratory paralysis 
usually proceeds death. 
Fatal Dose 
 1gm of root (Indian) or 250mg of root extract or 20 drops of 
tincture extract or 4 mg of allcaloid. 
Fatal period 
 3 to 24 hour maximum (average 6 hour) 
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Treatment 
1. Gastric lavage with warm water, and weak solution of 10 
dine in potassium 10dide, or tannic acid to precipitate the 
alkaloid or animal charcoal. 
2. Artificial respiration (oxygen). 
3. Atropine – 1mg given to prevent vagal inhibition of heart. 
4. 0.1% novocaine – 50ml controlling the cardiac arrhythmias. 
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BORAX 
Natural sources 
 Borax occurs naturally in evaporate deposits produced by the 
repeated evaporation of seasonal lakes.  The most commercially 
important deposits are found in Turkey and Wear Boron, California and 
other locations in the Southwestern, United states, the Atacama desert in 
chile, and in Tibet.  Borax can also be produced synthetically from other 
boran compounds. 
 Borax is replacing mercury as the preferred method for extracting 
gold in small scale mining facilities.  The method is called the borax 
method and was first discovered in the Philippines. 
 When a borax water solution is mixed with PVA glue (wood glue) 
a rubbery precipitate is formed, which is the result of cross-linking in the 
polymer. 
IUPAC name  : sodium tetraborate. 
     decalydrate. 
CAS number  : (1330-43-4) 
Molecular formula : OH.OBNa 2742  or 
     OH8].)OH(OB[Na 24542  
Molar mass   : 381.37 
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Appearance  : white solid 
Density   : 1.73g/cm3 (solid) 
Melting point  : 7410C 
Boiling point  : 15750C 
Flash point   : Sodium aluminate 
     Sodium gallate 
Other cations  : Pottassium tetraborate 
Related compounds : Boric acid, sodium perborate. 
Name 
 The origin of the name is traceable to the medieval latin borat, 
which comes from the Arabic buraq, which comes from either the 
perisan burab. 
Chemistry of the Borax 
 The structure of the anion ( )[ ]2455 OHOB  in borax.  The term borax 
is often used for a number of closely related minerals or chemical 
compounds that differ in their crystal water content. 
♣ Anhydrous borax ( 742 OBNa ) 
♣ Borax pentahydrate ( OH5.OBNa 2742 ) 
♣ Borax decahydrate ( OH10.OBNa 2742 ) 
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Borax is generally described as OH10.OBNa 2742 .  However, it is better 
formulated as ( ) OH8].OHOB[Na 24542 , since borax contains th
( ) −2454 ]OHOB[  ion.  In this structure, there are two four-coordinate boron 
atoms  (Two Bo4 tetrahedra) and two three co-ordinate boron atoms (two 
Bo3 triangles). 
 Borax is also easily converted to boric acid and other borates which 
have many applications.  It left exposed to dry air, it slowly loses its 
water for hydration and becomes the white and chalky mineral 
tincalconite ( OH5.OBNa 2742 ). 
 When borax is added to a flame, it produces a bright orange colour.  
This properly has been tried in amateur fireworks, but borax in this use is 
not popular because its waters of hydration, inhibit combustion of 
compositions and make it as inferior source of the sodium which is 
responsible for most of its flame colour, and which overwhelms the 
green contributed to the flame by boron. 
 However commercially available borax can be mixed with 
flameables such as methanol to give the characteristic green flame of 
born when ignited, which then slowly gives way to the characteristic 
yellow-orange flame of the sodium. 
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 Borax is natriumtetraborate, biborate of soda.  The main 
characteristic in this remedy is the great fear of downward motion, of 
laying a baby in a crib orbed, rocking a baby or carrying child down the 
stairs.  But also consider other downward motions, like the rhythms of 
horse-riding, rapidly going downhill, being on a boat or in an plane, 
dancing and swinging.  Borax will cure travel disease if that is caused by 
downward motion. 
 The cause for this great sensitivity to motion is a heightened 
sensitivity of the senses in nervous and worried persons.  They are easily 
frightened by music, sound, excitement or unexpected news.  Especially 
the downward motion aggravates all complaints in these sensitive 
people.  These movements cause nervous confusion and a great deal of 
dizziness. 
 Borax is an important remedy for babies.  Often the birth was 
traumatic or the baby came over time.  These children are very quiet and 
only drink a little bit.  In care of jaundice after birth they sleep a lot.  In 
their sleep they sometimes scream without particular reason, but for the 
rest they don’t make a sound.  They don’t easily gain weight and wake 
up often.  These babies are very sensitive to sound and movements in 
general. 
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 There are many complaints of in the mouth and on the tongue, 
causing problems with eating and nursing the child. 
 They feed course by downward movement, by sound, excitement 
and mental exertion.   
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PROPERTIES 
1. Difference forms of borax : 
Borax exist in three forms : 
a) Ordinary (or) prismatic borax. ( OH10.OBNa 2742 ) 
This is the common form of borax and is obtained when a 
solution of the salt is crystallized at room temperature (ie., 
below 600). 
b) Octahedral or Jeweler’s borax which is penta hydrate  
( OH5.OBNa 2742 ) and is obtained when the solution is 
crystallized above 600. 
c) Borax glass which is the anhydrous form and is obtained by 
heating the ordinary borax above its melting point until all 
the water of crystallization is given off.  It is a colourless 
glassy mass (density = 2.37).  It absorbs moisture from air 
and is gradually concerted into decahydrate form.    
2. Basic nature 
 It is sparingly soluble in cold water and fairly soluble in low 
water.  The solution is alkaline in reaction because borax is 
hydrolysed and it forms a mixture of sodium hydroxide a strong 
(base) and boric acid (a weak acid). 
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-Na2B4O7 + 3H2O   2Na BO2 + 2H3 BO3 
-Na B4O7 + 7H2O   Na OH + H3 BO3x 2 
 
-Na2B4O7 + 7H2O   4H3 BO3 + 2NaOH 
 
3. Action of heat 
 Ob heating above its melting point, it coses its water of 
crystallization and swells up to a white porous mass.  On further 
heating it melts to a liquid which then solidifies to a transparent 
glassy mass which consists of NaBO2 and B2O3. 
Na2B4O7 .10H2O                    Na2 B4 O7           2Na BO2+B2O2 
 
4. Action of acids 
  It reacts of concentrated HCl or concentrated H2SO4 to 
form sparingly soluble boric acid. 
Na2B4O7 + 2HCl +5H2O        2NaCl  + 4H3 BO3 
Na2B4O7 + H2 SO4 +5H2O        Na2 SO4 + 4H3 BO3 
Uses 
1.  In borax head test for the detection of basic radicals. 
2.  In the manufacture of enamels and glazes for pottery. 
3.  In making optical glass and boro-silicate glass ware. 
Weak  
acid
Strong 
alkali
Sodium  
metaborax
-10 H2O 
Heat
Boric 
anhydriate 
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4.  As a flux in metallurgy. 
5.  As a preservative for food. 
6.  In the manufacture of washing powders and soaps. 
7.  In leather and match industries. 
8.  Component of detergents. 
9.  Ingredient in enamel glazes. 
10. Component of glass, pottery and ceramics 
11. Fire retardant. 
12. Curing agent for snake skins. 
13. Swimming pool buffering agent  in control the pH. 
14. Buffer 
  Sodium borate is used in biochemical and chemical 
laboratories to make buffers, eg. For gel electrophoresis of DNA, such as 
TBE or the heaver SB buffer.  Borate buffers (usually at pH 8) are also 
used as preferential equilibration solution in DMP based cross linking 
reactions. 
15. Co-Complexing 
  Borax as a source of borate has been used to take advantage 
of the co-complexing ability of borate with other agents in water to 
complex various substances.  Borate and a suitable polymer bed are used 
to chromatograph non-glycosylated hemoglobin differentially from 
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glycosylated hemoglobin (chiefly Hb A/c), which is an indicator of long 
term hyperglycemia in diabetes mellitus.  Borate and a proprietary 
synthetic aminoacid.  Deselx (form Henkel) have been used to complex 
water “hardness” cautions to make a non-precipitating water “softener”.  
Borate alone does not have a high affinity for “hardness” cautions, 
although it has been use for that purpose. 
16.  Flux 
  A mixture of borax and ammonium chloride is used as a flux 
when welding iron and steel.  It lowers the melting point of the unwanted 
iron oxide allowing it to run off.  Borax is also used mixed with water as 
a flux when soldering  jewelery metals such as gold or silver.  It allows 
the melton solder to flow evenly over the joint in question.  Borax is also 
a good flux for pre-tinning tungsten with zinc-mauling the tungsten soft-
solder able.  
Borax Poisoning 
 Boric acid is a dangerous poison.  Poisoning from this chemical 
can be acute or chronic.  Acute boric acid poisoning usually occurs when 
someone swallows powdered roach-killing products that contain the 
chemical. 
 Chronic poisoning occurs in those who are repeatedly exposed to 
boric acid.  For example, in the past, boric acid was used to disinfect and 
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treat wounds.  Patients who received such treatment over and over again 
got stick, and some died. 
Poisonous ingredient : Boric acid. 
Where found 
4 Antiseptics and astringents 
4 Medicated powders 
4 Skin lotions 
4 Powders to kill roaches 
4 Some rodent and ant pesticides 
4 Photography chemicals 
4 Some paints 
4 Enamels and glazes 
4 Glass fiber manufacturing. 
 
Symptoms 
 The main symptoms of boric acid poisoning are blue-green vomit, 
diarrohea, and bright red rash on the skin.  Other symptoms may include, 
0 Blisters 
0 Collapse 
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0 Coma 
0 Convulsions 
0 Drowsiness 
0 Fever 
0 Law of desire to do anything 
0 Low blood pressure 
0 Significantly decreased urine output 
0 Sloughing of skin 
0 Twitching of facial muscles, arms, hands, legs and feet. 
Treatment :  Home treatment 
Ñ If the chemical is on the skin, remove by washing the area 
thoroughly. 
Ñ If the chemical was swallowed, seek medical treatment 
immediately. 
Before calling Emergency 
Determine the following information 
1 The patient’s age, weight and condition. 
1 The name of the product 
1 The time it was swallowed 
1 The amount swallowed 
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Treatment 
 Gastric lavage 
 Dialysis 
 Liquids by mouth or IV. 
Activated charcoae does not affectively treat (absorb) boric acid. 
Chronic poisoning 
 Manifestations of chronic poisoning may be  
i. Alopecia 
ii. Dry tongue 
iii. Anorexia 
iv. Kidney damage. 
Fatal dose 
 Children   - 5gm 
 Adults  - 15-20gm 
Fatal period  
  3-4 days. 
Post mortem appearances 
á Congestion of the stomach with several spots of erosions on its 
mucous membrane. 
á The brain may be oedematous 
á There may be echymosis on the inner surface of the pericardium. 
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á The liver and kidney show fatty degeneration. 
á The highest boron levels after poisoning have been reported in the 
brain liver and heart 
á Blood and urine samples should be collected for chemical analysis. 
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WHITE PEPPER 
 White pepper is prepared from ripe berries or by decorticating 
black pepper.  Bright red berries after harvest are detached from stalk 
and packed in gunny bags.  Bags are allowed to soak in slow running 
water for about one week during which bacteria routing occurs and 
pericarp gets loosened.  Then the berries are trampled under feet to 
remove any adhering pericarp, washed in water and then sun dried to 
reduce moisture content to 10-12% and to achieve a cream or  white 
colour.  White pepper is garnbled, sorted and packed in gunny bags, 
approximately 25kg white pepper is obtain and from 100kg ripe berries.  
 General food technology research institute, mysore, India improved 
the method in which fully mature but unripe berries, are harvested and 
boiled in water for 10-15 minutes to soften the pericarp.  After cooling, 
skin is rubbed off either manually or mechanically washed and sun dried 
to obtain white pepper.  Since no reeling operation is involved, product 
will be free from any unpleasant odour.  But white pepper produced by 
this method, gives pepper, powder of light, green colour due to 
gelatinization of starch in contrast to pure white powder obtained by 
traditional method. 
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Decorticated black pepper 
 This is a form of white pepper produced by mechanical 
decortications of outer skin, of black pepper.  Appearance of 
decorticated kernel is inferior to traditionally prepared white pepper, but 
is satisfactory when ground.  Also the milling operation requires 
considerable skill to avoid excessive volatile oil loss. 
Pepper oil 
 Oil can also be distilled white pepper but high price of white 
pepper and how oil yield don’t favour its commercial production. 
Quality attribute of  varieties of pepper 
Varieties 
Properties P1 P2 P3 P4 P5 P6 P7 
Prying % 35.3 35.7 27.8 34.7 35.7 32.9 33.6
Piperine % 5.30 6.50 4.80 4.80 5.30 4.94 5.57
Olerorisin % 11.78 12.20 10.40 10.40 12.33 8.27 10.01
Essential oil % 3.31 3.40 3.12 3.12 3.80 1.33 1.50
Structure of piperine 
Chemical names 
 1-piperoyl piperidine 
 (E-E)1- [5-1,3 Benzodioxol -5-yl)-1-oxo 
Penta dienyl piperidine 
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Molecular weight : 285.33 
Percentage composition 
C = 71.55% ,  H = 6.71%   N = 4.91% , O = 16.82% 
Molecular structure 
0 
0 
N 
Method of enuraction 48 
Piperine can be isolated from the oleoresin piperin nigrum of piper 
longum.  The powdered fruits. 
    The Indian Materia Medica – Vol.I A.K. Nadkarani 
 White pepper consists of fruits of piper nigrum divested of the  
dark outer skin, which is removed by soaking in water berries being 
subsequently dried and bleached in the sun.  Pungent and acid principles 
contained chiefly in the pericarp, are thereby removed. (uses are the 
same as those of piper nigrum).  White pepper forms an ingredient of a 
pill reputed to be a specific for checking the constant attacks of filarial 
fever, accompanying, elephantoid swellings.  It is known as hubhai 
sahfa, it is prepared thus, saturate white pepper and aconitum ferox in 
milk for three days, changing the milk every day with fresh milk.  Grind 
the drugs in ginger juice and make pills.  Dose in one pill thrice a day. 
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Ginger (Ziniber Officinale) 
Habit 
 Rhizome shout tuberous with erect leafy stems 0.6-1.2cm high 
leaves, narrow, distichous, subsecsile, on the sheaths. 
Flowers greenish with  small dark purple or purplish black. 
Distribution 
 Widely cultivated in tropical asia. 
Zingiher (Compendium of Indian medianal plants) 
 β - Bisabolene ar-curcumene, α - farnesene and zingiherene 
identified in oil from rhizomes of Indian plant.  Whereas rhizome oil 
from Ausiralian plant contained comphane, 1,8-cincole, geranial, herbal 
and phellandrene.  
Biological activity 
 (6)-shogaol 10.5 mg/kg., IV) 
 Showed triphasic effect on blood pressure, in rats, an initial fall 
followed by marked pressor response, brady cardia, and apnea.  It 
induced contractile response in isolated Juinea pig trachea at 100.0 mµ  
and should positive inotropic and chronotropic activities on isolated atria 
in rats at 3.6 mµ . 
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 Gingerols I & II from rhizomes potentiated contractions induced by 
prostaniods.  (except PGD2), and inhibited contractions produced by 
PGD2, TXH2 and LT on isolated blood vessels, of mice and rats because 
of their prostograndin-related chemical structures, gingerols acted as 
modulator of eilosanoid responses in vascular smooth muscles. 
Arthritis patients report pain relief with powdered ginger. 
 
ACTIONS AND MEDICINAL USES 
 The rhizome is sweet, pungent, heating, appetizer, laxative, 
stomachic, aphrodisiac, carminative, useful in diseases of the heart, and 
the throat, dyspepsia, inflammation, kaba, and vatha disease, bronchitis, 
asthma, vomiting. 
 It is useful in indigestion, vomiting, asthma, piles and abdominal 
troubles. 
 The plant is used in an aromatic, stomachic and stimulant. 
 Externally it is applied to boils and enlarged glands. 
 It is prescribed as an adjuvant to many tonic and stimulating 
remedies. 
 The root skin is used as a carminative and is said to opacity of the 
cornea. 
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Ginger Juice 
Analysis of a bazzar sample of runs ginger gave the following values. 
1. Moisture  - 80.9% 
2. Protein  - 2.3% 
3. Fat   - 0.9% 
4. Fibre   - 2.4% 
5. Carbohydrates - 12.3% and  
6. Minerals  - 1.2% in 100g ginger 
 Ca  - 20mg 
 P  - 60mg 
 Fe  - 2.6mg per 100g ginger. 
Ginger contains traces of Iodine and flurocine the vitamins present in 
raw ginger are, 
 Thiamine - 0.6mg 
 Riboflavin - 0.03mg 
 Niacin - 0.60mg 
 Vitamine - 6.0mg per 100g ginger. 
The value reported for carotene in the fresh rhizomes is 40µg/100g. 
 Ginger contains small qualities of glucose.  Fructose and sucrose, 
raffinose is probably present in trails.  The principal carbohydrate of the 
rhizome is starch .  Ginger contains free amino acids like, 
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1. Glutamic acid - γ - amino butyric acid 
2. Aspartic acid - valine 
3. Serine  - phenyl alanine 
4. Glyceine  - asparagines 
5. Threonine  - lysine 
6. Alanine  - cystine 
7. Glutamine  - leucine and 
8. Arginine  - proline 
 The characteristic pleasant and aromatic odour of ginger in due to 
an essential oil, which can be separated from the rhizome by steam-
distillation. 
 The pungent principles of ginger are non-volatile.  They can be 
extracted from coarsely, ground dried spice by percolation, with acetone, 
ethyl alcohol or ethyl other.   
 The quality of the oleoresin known in tracks as ‘GINGERIN’ vary 
according to the source material, servant employed and the method or 
preparation gingerol is obtained from the oleoresin as highly pungent, 
optically active light brown viscous oil. 
 Ginger is valued in medicine as a carminative and stimulant to the 
gastro-intestinal tract. 
 Ginger is reported to contain an anti-histamic factor.  
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BIO-CHEMICAL ANALYSIS OF NABI MATHIRAI 
PREPARATION OF THE EXTRACT 
 5gms of  Nabi mathirai  was weighed accurately and placed in a 
250ml clean beaker.  Then 50ml distilled water was added and dissolved 
well.  Then it was boiled well for about 10 minutes.  It is cooled and 
filtered in a 100ml volumetric flask and then it is made up to 100ml with 
distilled water.  This fluid was taken for analysis. 
QUALITATIVE ANALYSIS 
 
S.NO. EXPERIMENT OBSERVATION INFERENCE
1. TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean 
test tube. 2ml of 4% 
Ammonium oxalate solution 
is added to it. 
No white precipitate 
is formed 
Absence of 
calcium 
2. TEST FOR SULPHATE 
2ml of the extract is added 
to 5% barium chloride 
solution. 
No white precipitate 
is formed. 
Absence of 
sulphate 
3. TEST FOR CHLORIDE 
The extract is treated with 
silver nitrate solution. 
A white precipitate 
is formed 
Indicates the 
presence of 
chloride 
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4. TEST FOR CARBONATE 
The substance is treated with 
concentrated HCl. 
No brisk effer 
vessence is formed. 
Absence of 
carbonate. 
5. TEST FOR STARCH 
The extract is added with 
weak iodine solution. 
No blue colour is 
formed. 
Absence of 
starch. 
6. TEST FOR IRON-FERRIC 
The extract is treated with 
concentrated Glacial acetic 
acid and potassium ferro 
cyanide. 
No blue colour is 
formed. 
Absence of 
ferric iron. 
7. TEST FOR IRON FERROUS 
The extract is treated with 
concentrated nitric acid and 
ammonium thiocyanide. 
No blood red colour 
is formed. 
Absence of 
ferrous Iron. 
8. TEST FOR PHOSPHATE 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed. 
Absence of 
phosphate. 
9. TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin. 
10. TEST FOR TANNIC ACID 
The extract is treated with 
ferric chloride. 
Blue black 
precipitate is 
formed. 
Indicates the 
presence of 
Tannic acid. 
11. TEST FOR UNSATURATION 
Potassium permanganate 
solution is added to the 
extract. 
It gets decolourised. 
Indicates the 
presence of 
unsaturated 
compound. 
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12. TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test 
tube and allowed to boil for 
2mts and added 8-10 drops 
of the extract and again boil 
it for 2mts. 
No colour change 
occurs. 
Absence of 
reducing 
sugar. 
13. TEST FOR AMINO ACID 
One or two drops of the 
extract is placed on a filter 
paper and dried it well.  
After drying, 1% Ninhydrin 
is sprayed over the same and 
dried it well. 
Violet colour is 
formed. 
Indicates the 
presence of 
Amino acid. 
 
RESULT 
 The given sample of  Nabi Mathirai contains Chloride, 
Unsaturated compound and  Amino acid.  
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TOXICITY STUDIES 
Siddha system, an ancient system of medicine was introduced by 
the Siddhar’s.  This system consists of medicines for both internal as well 
as external uses. In Order to standardize such medicines it is necessary to 
evaluate its safety and also to find whether it  possess toxic properties or 
not.  So toxicity studies are conducted on the animals like mice, albino 
rats etc.   
       While doing toxicological studies we need the help of following 
departments. 
 
1. Medicinal botany and Pharmacognosy  
2. Pharmacology  
3. Biochemistry  
4. Histopathology  
5. Pharmacy  
6. Animal House  
7. Bio – Statistics 
While doing animal study, there are some criteria and condition to 
be noted.  They are given below. 
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Selection of Animal species: 
1. Usually animal experiments are conducted on mice, albino rats, 
rabbit and dogs. Young and immature animals should be selected 
for the study.  
2. While selecting mice, it should be 20 – 25 gm weight and 8-12 
weeks of growth.  
3. In case of albino rats, it should be 80-120gm weight and 12 weeks 
growth.  
4. Virgin animals should be selected.  
Preparation of animals: 
1. Animals should be properly caged and should be fed properly with 
adequate diet.  
2. Allow the animals to be in the cage for 5 days before drug 
administration in-order to make them accustomed to the new 
environment.  
3. The temperature maintained in the animal house should be 19˚C - 
25˚C and the humidity should be 30%  
4. The animal house should be 12 hrs dark and the remaining 12hrs 
full of light.  
5. The test animal must be free from infections.  
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Preparation of test drug: 
1. The drug should be soluble in honey, water or any other liquid.  So 
that it can be administered orally.  
2. The drug should be stable. 
3. The drug should be prepared whenever necessary.  
4. Drug should not have hyperacidity or hyper alkalinity and high 
toxicity. 
 Preparation of the doses: 
1. While doing animal study the dose of the drug given is determined 
on the basis of body weight of the animal.  
2. In case of mice and albino rat, the dose of the drug must be 1ml for 
100gm body weight.  
3. When water soluble drugs are given, it must be 2ml/100gm body 
weight.  
4. The adjuvant (anubanam) should be free from toxicity.  
PROCEDURE: 
a. Administration of drug 
During drug administration care should be taken that the drug does 
not enter into the respiratory passage. Before drug administration, the 
animal has to be fasted.  In case of mice and albino rat` the fasting period 
is 3hrs and 12hrs respectively.  The weight of the animal has to be noted 
before drug administration.  Then the drug is administered to the animal. 
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After administration of the drug, the animal should be fed after a lapse of 
1 to 2 hrs in mice and 3-4 hrs in albino rats. 
b. Number of animals and dose levels 
The dose of the drug given in the animal depends upon 
1. Body weight of the animal 
2. Metabolic rate of the animal  
While conducting acute toxicity study the number of animals in 
each group should be five (i.e six groups). Animals of both sex should be 
used. In case of chronic toxicity study the animals are divided into 3 
groups, each group consisting of 5 animals. 
Observation: 
In acute toxicity study, the animals are carefully observed during 
the first 30min and then observed for 24hrs. During that period, the 
animal may show changes in the skin, eye, mucous membrane, blood 
circulation, respiratory movements and the neurological problems may 
arise. 
In case of sub acute toxicity study, the animals have to be observed 
for 28 days.  For chronic toxicity study the animals have to be observed 
for 90 days or sometimes up to 1 year.  Some researchers conduct the 
chronic toxicity study for the whole life time of the animal. 
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Body weight of the animal: 
  The weight of the animal must be taken four times during the 
course of study. 
¾ First before drug administration.  
¾ 1 week after drug administration.  
¾ Then 2 weeks after drug administration.  
¾ Regularly recorded in a fixed interval during the period of drug 
administration.  
¾ Finally before sacrificing the animal.  
Data and report: 
At the end of the animal study, the following data’s must be given. 
¾ Number of animals selected for the study.  
¾ Number of animals died due to the toxicity of the drug given.  
¾ Number of animals sacrificed at the end of animal study.  
¾ Changes in animal behaviour due to acute and chronic toxicity. 
¾ Histopathological changes in the internal organs such as liver, 
kidney, heart etc.  
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ACUTE TOXICITY STUDY 
TOXICITY STUDY 
The toxicity evaluation of  Nabi mathirai is carried out in two 
phases. 
Phase I  -  Acute toxicity study  
Phase II  -   Chronic toxicity study 
Animals: 
Wistar albino rats bred in the animal house attached to the Post 
Graduate, Pharmacology Department, Govt. Siddha Medical College, 
Palayamkottai were used. 
Sex: 
¾ Animals of both sexes were used. 
Weight: 
¾ Animals weighing between 80 – 120 gm were selected. 
Food and water: 
¾ The animals were maintained with standard animal feed and water 
ad-libitum. 
Number of animals: 
30 rats were divided into 6 groups with, each group consisting of 5 
rats. 
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Dose levels: 
The following dose levels were arbitrarily fixed by presuming 
range of least toxic to high toxic doses. 
I Group                  Control 
          II Group                 40mg/100g body weight of animal  
III Group               80mg/100g body weight of animal 
IV Group               160mg/100g body weight of animal 
V Group                320mg/100g body weight of animal 
VI Group               640mg/100g body weight of animal  
Route of administration: 
Oral administration. 
Preparation of the test drug for administration: 
The drug was weighed and taken.  Then water was added as a 
suspending agent.  The mixture was ground well before the 
administration.  The preparation was done in such a way such that 1ml of 
suspension containing doses ranging from 40-80mg of  Nabi Mathirai  
which are given to the respective groups, as classified above in the doses 
level. The drug was administered in the morning and observed. 
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OBSERVATIONS: 
The following details are recorded 
1. Stimulation  
• Hyper activity 
• Pyloerection 
• Twitching 
• Rigidity 
• Irritability 
• Jumping 
• Clonic convulsion 
• Tonic convulsion. 
2. Depression 
• Ptosis 
• Sedation 
• Sleep 
• Loss of Pinna Reflex 
• Ataxia 
• Loss of muscle tone 
• Analgesia 
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3. Autonomic effects  
• Straub tail 
• Laboured respiration 
• Cyanosis 
• Blanching 
• Reddening 
• Abnormal Secretion 
At the end of 24 hours, the number of animals live or dead in  
each group was noted and approximate LD 50 is tried to determine. 
The tabular column was made and the results were analyzed. 
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TABLE NO.1 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A CONTROL DOSE. 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II DEPRESSION: 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of Pinna Reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
III Autonomic effects: 
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening  - - - - 
IV Number of animals 
dead: 
- - - - 
 
+ Positive sign    - Negative sign 
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TABLE NO.2 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A DOSE OF 40mg/100g BODY WEIGHT OF 
ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II Depression: 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
II.Autonomic effects:  
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV Number of animals 
dead: 
- - - - 
 
+ Positive sign     - Negative sign 
103 
 
TABLE NO .3 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A DOSE OF 80mg/100g BODY WEIGHT OF 
ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II Depression 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of Pinna Reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
III.Autonomic effects:  
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV Number  of animals 
dead: 
- - - - 
  
+ Positive sign     - Negative sign 
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TABLE NO.4 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A DOSE OF 160mg/100g BODY WEIGHT 
OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II Depression: 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of Pinna Reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
III Autonomic effects: 
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening  - - - - 
IV Number of animals 
dead: 
- - - - 
 
+ Positive sign    - Negative sign 
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TABLE NO.5 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A DOSE OF 320mg/100g BODY WEIGHT 
OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II Depression: 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of Pinna Reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
III Autonomic effects: 
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening  - - - - 
IV Number of animals 
dead: 
- - - - 
 
+ Positive sign - Negative sign 
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TABLE NO.6 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF  
NABI MATHIRAI, AT A DOSE OF 640mg/100g BODY WEIGHT 
OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I Stimulation: 
Hyper activity - - - - 
Pyloerection - - - - 
Twitching - - - - 
Rigidity - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II Depression: 
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of Pinna Reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesia - - - - 
III Autonomic effects: 
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening  - - - - 
IV Number of animals 
dead: 
- - - - 
 
+ Positive sign    - Negative sign 
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RESULT 
ACUTE TOXICITY STUDY: 
 The said parameters in acute toxicity study were observed on 
various six groups (Group-I, Group-II, Group-III, Group-IV, Group-V 
and Group VI). Group-II  to VI were administered with the drug such as, 
40mg , 80mg, 160mg, 320mg  and 640mg / body weight of the animal 
respectively. The results were tabulated in Table-I to VI. 
 From the Table I – VI it is being found that the drug “Nabi 
mathirai” did not produce any mortality even up to 640mg /100g body 
weight of the animal. 
 Since it is practically difficult to administrate more than  
640mg/ 100g body weight of the animal ie, Small species (Wistar albino 
rats) and there is no mortality of the animals, taken for the study  it is 
unable to calculate the lethal dose in this preliminary acute toxicity study. 
 So, it is inferred that the drug is found to be safe up to 640mg/100g 
body weight of the animal.    
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CHRONIC TOXICITY STUDY 
Introduction: 
Nabi mathirai  is used for the following conditions in siddha 
system of Medicine. 
• Suram (fever) 
• Headache  and 
• All type of fevers. 
The duration of administration was 90 days.  Since the drug is 
usually given for a long term in chronic ailments.  It was decided to find 
out the chronic toxicity of the drug in experimental animals. 
Animals: 
      Wistar albino rats bred in the animal house attached to the Post 
Graduate, Pharmacology Department, Govt. Siddha Medical College, 
Palayamkottai were used. 
Sex: 
• Animals of both sex were used. 
Weight: 
• Animals weighing between 80 – 120 gm were selected. 
Food and water: 
• The animals were maintained with standard animal feed and water 
ad-libitum. 
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Number of animals: 
       15 rats were divided into 3 groups each group consisting of 5 rats. 
Selection of the dose: 
      Two doses were selected.  These doses did not have any acute toxicity 
effect and presumed to be safe for long term administration in animals. 
I Group                 Control 
II Group                40mg/100g body weight of animal. 
III Group               80mg/100g body weight of animal  
Route of administration: 
       Oral administration 
  Preparation of the drug for administration: 
      The drug was weighed and taken.  Then water was added as 
suspending agent.  The mixture was ground well before administration.  
The preparation was done in such a way so as 1ml of suspension 
contained 40-80mg of  Nabi mathirai  for the groups taken.  The prepared 
drug was administered once a day (morning) for 90 days. 
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Observation: 
      The following details were recorded before the beginning of drug 
administration 
1. Body weight of the animals  
2. Haematological Investigations  
a. WBC Total count  
b. WBC Differential count  
c. Haemoglobin %  
The above parameters were recorded at 30 days, 60 days and at the 
end of the experiments and the results were tabulated. 
One Animal from Each group, were sacrificed at the end of the 
experiment and were dissected.  The viscera like Heart, Liver and Kidney 
were removed from each animal and were preserved in 40% formalin and 
sent for Histo-pathological studies. 
Histopathological procedure: 
      The sections were stained with haemotoxilin and eosin and the 
histopathological report was given by Dr. K. Swamy nathan, M.D. 
(Path), Professor of Department of pathology, Government  Medical 
College, Tirunelveli.  
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TABLE - 7 
Changes in the parameters of weight and hematological indices in 
Group I animals (Control) 
 
S.No Blood At O' 
day 
At 3Oth 
day (Mean)
At 60th day 
(Mean)
At 90th day 
(Mean)
1. WBC 
Total count 
5100/cumm 5100/cumm 5000/cumm 4900/cumm
2. Differential Count 
 Neutrophil 65% 64% 65% 63% 
 Eosinophil 2% - 01% - 
 Basophil - - - - 
 Lymphocyte 33% 36% 34% 37% 
 Monocyte - . - - 
3. Haemoglobin % 11gm 10.6gm 11gm 11gm 
4. Body Weight 100gm 120gm 150 gm 180 gm 
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TABLE – 8 
Changes in the parameters of weight and haematological indices in 
Group II animals – 40mg/body weight of the animal. 
S.No. Blood 
At O' day
(Mean) 
At 30th 
day 
At 60th day 
(Mean) 
At 90th 
day 
1. 
WBCTotal 
Count 
5800/cumm 5850/cumm 5860/cumm 5800/cumm
2. Differential Count 
 Neutrophil 61% 63% 66% 62% 
 Eosinophil 3% 4% 2% 1% 
 Basophil - - - - 
 Lymphocyte 36% 33% 32% 37% 
 Monocyte - - - - 
3. Haemoglobin% 9.3gm 9.8gm 9.5gm 9.5gm 
4. Body Weight 100 gm 103gm 105 gm 108gm 
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TABLE – 9 
Changes in the parameters of weight and haematological indices in Group 
III animals – 80mg/body weight of the animal. 
S.No. Blood At O' day 
(Mean)
At 30th day 
(Mean)
At 60th day 
(Mean) 
At 90«» 
day 
1. WBC Total 
count 
6000/cumm 6000/cumm 6100/cumm 6200/cumm
2. Differential Count 
 Neutrophil 64% 62% 60% 64% 
 Eosinophil 2% 4% 1% 3% 
 Basophil - - - - 
 Lymphocyte 34% 34% 39% 33% 
 Monocyte - - - - 
3. Haemoglobin % 10gm 10gm 10.2gm 10gm 
4. Body Weight 100gm 104gm 104gm 108gm 
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ANNEURE - I 
HISTOPATHOLOGICAL STUDIES ON ANIMALS 
[Wistar Albino Rats] 
 
Chronic toxicity studies 
Group I        
  Control 
Liver      
  Normal  (Represented in Fig.1) 
Kidney     
  Normal (Represented in Fig.2) 
Heart        
  Normal (Represented in Fig.3) 
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ANNEURE - II 
HISTOPATHOLOGICAL STUDIES ON ANIMALS 
[Wistar Albino Rats] 
 
Group II 
The effect of Nabi mathirai at the dose of 40mg /body weight of the 
animal. 
 Liver: 
No Remarkable changes.  (Represented in Fig.4). 
Kidney:    
          No Remarkable changes.  (Represented in Fig.5). 
Heart:        
No Remarkable changes. (Represented in Fig.6). 
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ANNEURE - III 
HISTOPATHOLOGICAL STUDIES ON ANIMALS 
[Wistar Albino Rats] 
 
Group –III 
The effect of Nabi mathirai at the dose of 80mg/body weight of the 
animal. 
Liver: 
           No Remarkable changes.  (Represented in Fig.7) 
Kidney: 
Focal cloudy swelling of Proximal Convulated Tubule.  
(Represented in Fig.8) 
 
Heart: 
Myofibrils shows congestion.(Represented in Fig.9) 
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RESULT 
 
 The mean value of body weight and haematological indices for the three 
groups of rats, each group containing 5 animals with two different dosage levels 
were observed and the results were tabulated in Tables 7, 8 and Table 9, for the 
control, 40mg/body weight of the animal and 80mg/body weight of the animal, 
dose groups respectively.  
Histopathological studies reveal that the drug  Nabi mathirai on long 
term administration shows pathological changes in the  kidney and heart. So, 
the drug may produce less toxic effects on long term use.  
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BIO-STATISTICAL ANALYSIS 
PROBIT ANALYSIS 
Probit means probability Unit: 
      Biological assays refers to assessment of the potency of vitamins, 
hormones, toxicants and drugs of all types by means of the responses produced 
when doses are given to experimental animals.  In every dose response 
situation, two components must be considered: the stimulus and the subjects.  
The stimulus is applied to the subject at a stated dose namely concentration, 
weight, time or other appropriate measure.  The subjects manifest a response.  
The level of intensity below which the response does not occur and above 
which the response occurs, such a value has often been called threshold or 
limen, but the term Tolerance is now widely accepted.  
Median Effective Dose (ED50): It is the dose which produces the desired 
response in half the animal population tested.  
Median Lethal Dose (LD50): It is the dose which kills half the population of 
the animals tested.      
LD50 measurement (Toxicity): 
¾ If the test compound shows any pharmacological activity then the LD50 
of the drug is determined. 
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¾ By determining the LD50 , we can justify whether to proceed with the 
drug or not.  
Acute toxicity study analysis:  
Group 
Dose in mg/ body 
weight of the 
animal 
No. of Rats 
No. of  Rats 
died 
    I 40 5 - 
    II 80 5 - 
    III 160 5 - 
    IV 320 5 - 
    V 640 5 - 
 
          Since, there is no mortality of the animals in Acute Toxicity Study lethal 
dose  of the drug  could not be calculated.  
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Chronic toxicity study: 
Groups Dose No. of Rats Days 
No. of rats 
died 
Group I 40 5 
0 - 
30 - 
60 - 
90 - 
Group II 80 5 
0 - 
30 - 
60 - 
90 - 
 
        In case of Chronic Toxicity Study, with the help of physiological 
parameters such as Hematological investigations and with the histopathological 
studies the drug reaction with-in the animal can be assessed and are being 
tabulated respectively. 
       Lethal dose of the drug  Nabi mathirai can be calculated with  higher dose 
level of the drug which can be done in further studies.  
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DISCUSSION 
 
 The author went through the toxicity studies on albino rats for  the 
medicine Nabi mathirai. 
 The present study with Nabi mathirai was conducted with an 
objective to find out, whether this drug has got any side effects or 
adverse reactions in long term administration to patient.  
 Nabi mathirai  is used to treat Fever, Headache and All type of 
fevers in day to day practice.  
 The bio-chemical studies of the drug bring out the presence of 
Unsaturated compound, Tannic acid, and Amino acid. 
 While studying this drug experimentally, every precaution  were 
taken, as it is administered. With this view, the drug was administered 
with proper adjuvant in all experiments conducted. 
 A brief outline of the study is given below for discussion. 
Acute toxicity study: 
The following 5 graded doses were given to animals in this study. 
1. 40 mg /100g body weight of the animal  
2. 80 mg /100g body weight of the animal 
3. 160 mg /100g body weight of the animal 
4. 320 mg /100g body weight of the animal 
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5. 640 mg /100g body weight of the animal 
As per the findings of the study it is found that the single oral 
doses up to 640 mg /100g body weight of the animal, Nabi mathirai did 
not produce any morality, even at the end of 24 hrs.  
Chronic toxicity study: 
 The following 2 graded doses were given to the animals and one 
group is kept as control was administered with water in this study. 
 Group I - Control 
 Group II - 40mg /100g body weight of the animal 
 Group III - 80mg /100g body weight of the animal 
 As per findings of long term administration of  Nabi mathirai in 
the dose at the level of 40mg/100mg body weight of the animal and 
80mg/100mg body weight of the animal produce myofibrils showing 
congestion of the heart, Proximal Convoluted Tubule (PCT) of the 
kidney shows focal cloudy swelling.                                 
 Bio-Statistical measures to the Acute and Chronic toxicity studies, 
the drug  Nabi mathirai  is found to be Safe upto 640mg/100g body 
weight of the animal in acute toxicity study and the lethal dose of the 
drug Nabi mathirai  could not be calculated as there is no mortality of 
the animals taken for the study.  
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The toxicity effects of Nabi mathirai were observed in chronic 
toxicity studies have been proved in long term use in rats. So the dose 
has to be reduced to smaller than dose of  80 mg for the safety of patients 
while long term use in future. 
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SUMMARY 
 
Nabi mathirai  is prepared according to the process found in the 
text  Skitcha Rathna Deepam Ennum Vaidhya Sinthamani –II part.  
This well known drug is used in Siddha practices, by a large number of 
siddha physicians.  
 The aim of this dissertation is to study the acute and chronic 
toxicity of the drug  Nabi mathirai  , administered at various presumed 
moderate dosage, in the experimental animals.  
 In Review of literature, the ingredients of Nabi mathirai are 
discussed in depth, with focus of special features and medicinal uses, 
especially for diseases like Fever, Headache and All type of fevers. 
The bio-chemical studies of the drug bring out the presence of 
Unsaturated compound, Tannic acid and Amino acid. 
The preparation of the medicine Nabi mathirai , is given in the 
previous chapter. The acute and chronic toxicity studies are done as 
follows. 
 The wistar albino rats of both sexes were selected from the animal 
house at the Government Siddha Medical College, Palayamkottai. The 
rats of weight 80-120 gm were fed with standard food and water. 
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 To evaluate the acute toxicity study 30 rats were selected and 
divided into 6 groups, each group consisting of 5 rats and they were 
administered with the drug in different graded dosages ranging from 40 
to 640mg/100g animal, orally. The animals were observed and the 
details were recorded. The drug did not produce any mortality even up to 
24 hrs, so the drug is found to be safe up to 640mg / 100 gm body weight 
of animal on Acute Toxicity. The chronic toxicity study was conducted 
for about 90 days duration. In this study two dose levels were selected 
from acute toxicity study for the drug administration. 15 rats were 
selected and divided into three groups, each group consisting of 5 rats. 
 The first group kept as control by administered only with placebo 
or water. Second group was administered with Nabi mathirai  at the 
dose of 40mg / 100g body weight of animal and the third group with  
80mg /100g body weight of animal. 
 The blood samples were taken before and after these studies. 
Periodical blood sample were taken in chronic study. Then blood 
samples were sent to laboratory for Haematological Evaluation.  
One animal from each group were sacrificed at the end of the 
experiment. Heart, liver and kidney were removed from the animal and 
sent to Pathologist for Histopathology report.  
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           The result shows pathological changes in Kidney and Heart, that 
were presented in tables with relevant photos.  
On applying Bio-Statistical measures to the Acute and Chronic 
toxicity studies, the drug Nabi mathirai is found to be Safe upto 
640mg/100g body weight of the animal and the lethal dose of the drug 
Nabi mathirai  could not be calculated as there is no mortality of the 
animals taken for the study.  
 It is to be noted that the physicians should take precautions while 
prescribing the Drug Nabi mathirai  regarding its dosage, anupanam, 
pathiyam (diet restrictions) and other principles of treatment. This is just 
a preliminary study and it will be useful for further researches.  
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CONCLUSION 
 From the acute studies conducted, we came to know that Nabi 
mathirai  did not produce death even up to the dose of 640mg as 
random. 
 Heamatological report also has no significant changes. 
 In Histopathological studies of the kidney and heart shows mild 
changes. 
 Therefore, we come to conclusion that even upto 640mg of Nabi 
mathirai never produce death in man. 
 Also the doses taken in Acute and Chronic study did not produce 
any mortality in animals.  But in chronic toxicity study produced mild 
histopathological changes in the kidney and heart.  Even this may be due 
to continuous administration of this drug for a long period at relatively 
higher doses when compared to man. 
 Because an ideal man of 70kg body weight requires 100mg of the 
drug 2 times daily.  So, a rat of 100gm body weight requires only 
0.43mg of the drug one time daily. But we have given above the normal 
dose.  These are 4 to 8 times more than human dose. 
 So, we can come to conclusion that if the drug was normal dose it 
might not produce any pathological changes. 
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 The aim of giving such a high dose was to find out the type of 
toxicity if the drug is given in abnormal high doses. 
 This toxicity due to overdose could occur in patient.  If  proper 
dose is not prescribed by the physician or followed by the patient. 
 So, the  recommended  human dose may not produce any ill effects 
and this must be proved by further animal study and also by clinical 
studies by volunteers. 
 This dissertation work is the first step for continuous research in 
this title. 
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